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Urine contains an immense amount of information related to its physical, chemical, 
and biological components; hence, it is a promising tool in detecting various diseases. 
Available methods for detecting hematuria (blood in the urine) are not accurate. 
Results are influenced by many factors, such as, health and vitals of the patients, 
settings of the equipment and laboratories, which leads to the false positive or false 
negative outputs. This necessitates the development of new, accurate and easy-access 
methods that save time and effort. This study demonstrates a label-free and accurate 
method for detecting the presence of red and white blood cells (RBCs and WBCs) in 
urine by measuring the changes in the dielectric properties of urine upon increasing 
concentrations of both cell types. The current method could detect changes in the 
electrical properties of fresh urine over a short time interval, making this method 
suitable for detecting changes that cannot be recognized by conventional methods. 
Correcting these changes enabled the detection of a minimum cell concentration of 102 
RBCs per ml which is not possible by conventional methods used in the labs except 
for the semi-quantitative method that can detect 50 RBCs per ml, but it is a lengthy 
and involved procedure, not suitable for high volume labs. This ability to detect a very 
small amount of both types of cells makes the proposed technique an attractive tool 
for detecting hematuria, the presence of which is indicative of problems in the 
excretory system. 
Furthermore, urolithiasis is also a very common problem worldwide, affecting adults, 
kids, and even animals. Calcium oxalate is the major constituent of the urinary tract 
stones in individuals, primarily due to the consumption of high-oxalate foods. The 
occurrence of urinary oxalate occurs by endogenous synthesis, especially in the upper 
urinary tract. In a normal, healthy individual, the excretion of oxalate ranges from 10 
to 45 mg/day, depending on the age and gender, but the risk of stone formation starts 
at 25 mg/day depending on the health history of the individual. This study also 
addresses the detection of the presence of calcium oxalate in urine following same 
label free approach. This can be done by measuring the changes in the dielectric 
properties of urine with increasing concentrations of calcium oxalate hydrate 





properties of urine over a time interval in samples containing calcium oxalate hydrate 
even at a concentration as low as 10 μg/mL of urine, making this method suitable for 
detecting changes that cannot be recognized by conventional methods. The ability to 
detect very small amount of stones makes it an attractive tool for detecting and 
quantifying stones in kidney. 
Using a non-invasive method which also works as a precautionary measure for early 
detection of some severe ailments, hold a good scope. It forms the basis of the 
cytological examinations and molecular assays for the diagnosis of several diseases. 
This method can be considered a point-of-care test because the results can be 
instantaneously shared with the members of the medical team. Based on these results, 
it is anticipated that present approach to be a starting point towards establishing the 
foundation for label-free electrical-based identification and quantification of an 
unlimited number of nano-sized particles. 
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Title and Abstract (in Arabic) 
 
 الدم و الحصى في البول  خاليا الخصائص الكهربائية للكشف عن
 صالملخ
 والبيولوجية؛ والكيميائية الفيزيائية بمكوناته المتعلقة المعلومات  من هائلة كمية البول على يحتوي
 عن للكشف المتاحة الطرق .المختلفة الكثير من األمراض  عن الكشف في واعدة أداة مما يجعله
 المرضى من العوامل من بالعديد  النتائج تتأثر كما. دقيقة ليست  (البول في الدمة )دمويال بيلةال
 أساليب  تطوير يستلزم وهذا. كاذبة إيجابية  أو سلبية نتائج إلى يؤدي مما المختبر، وإعدادات 
 من خالية طريقة  الدراسة هذه توضح . والجهد  الوقت  توفر الوصول وسهلة ودقيقة جديدة
 كرات  و الحمراء الدم كرات ) والبيضاء الحمراء الدم خاليا وجود  عن للكشف ودقيقة الملصقات 
 عند  للبول الكهربائي  العزل خصائص  في التغيرات  قياس طريق عن  البول في ( البيضاء الدم
 الخواص  في  التغيرات  اكتشاف الحالية للطريقة يمكنا. الخالي من النوعين كال تركيز زيادة
 الكتشاف مناسبة الطريقة هذه يجعل مما رة،قصي زمنية فترة خالل الطازج للبول الكهربائية
 الحد  اكتشاف التغييرات  هذه تصحيح أتاح. التقليدية بالطرق عليها التعرف يمكن ال التي التغيرات 
 الطرق خالل من ممكن غير أمر وهو مل، لكل حمراء دم كرات  210 من الخلية لتركيز األدنى
 كرة 50 عن الكشف يمكن التي الكمية شبه  الطريقة باستثناء المختبرات  في المستخدمة التقليدية
 القدرة هذه. الكبير  اإلنتاج ذات  للمختبرات ة مناسب غيرو  ،ومعقدة طويلة لكنها مل، لكل حمراء دم
 جذابة أداة المقترحة  التقنية تجعل الخاليا من النوعين كال من جدًا صغيرة كمية اكتشاف على
 .اإلخراج جهاز في مشاكل وجود  على تدل التي  دموية، بيلة عن للكشف
 تصيب  حيث  لم،العا أنحاء جميع في شائعة مشكلة أيًضاة بوليالحصى ال عتبرذلك، ت على عالوة
 المسالك لحصى الرئيسي المكون هي الكالسيوم أكساالت . الحيوانات  وحتى واألطفال البالغين
 تكون يحدث  .األكساالت  عالية األطعمة استهالك إلى أساسا ذلك ويرجع ، األفراد  في البولية
 الطبيعي الفرد  في .العلوي البولي الجهاز في وخاصة، الداخلي التخليق طريق عن البول أكساالت 
 خطر لكن والجنس، العمر حسب  ،ميو/ ملغ 45 و 10 بين األكساالت  إفراز يتراوح ،يوالصح
 اكتشاف أيًضا الدراسة هذه تتناول. للفرد  الصحي التاريخ حسب  يوم/ملغ 25 من يبدأ الحجر تكوين
 بذلك القيام يمكن. الملصقات  من الخالية الطريقة  نفس باتباع البول في الكالسيوم أكساالت  وجود 





O)2.H4O2(CaC .الكهربائية الخواص  في الديناميكية التغيرات  اكتشاف الحالية للطريقة يمكن 
 بتركيز حتى الكالسيوم أكساالت  هيدرات  على تحتوي التي العينات  في زمنية فترة مدى على للبول
 عن للكشف مناسبة الطريقة هذه يجعل مما  البول، من مل/ميكروغرام 10 إلى يصل منخفض 
 كمية اكتشاف على القدرةألساليب التقليدية. ا بواسطة عليها التعرف يمكن ال التي التغييرات 
 .الكلى في الحصى وقياس الكتشاف جذابة أداة يجعلها الحصى من جدًا صغيرة
 يعد  الشديدة األمراض  بعض  عن المبكر للكشف وقائي كتدبير تعملجراحية  غير طريقة ستخداما
 العديد  لتشخيص  الجزيئية والمقايسات  الخلوية الفحوصات  أساس يشكل . هذا األسلوب جيد  نطاق
 مشاركة يمكن ألنه الرعاية نقطةر عند اختبا بمثابة الطريقة هذه اعتبار  يمكن. األمراض  من
 الحالي نهجنا يكون أن نتوقع، النتائج هذه إلى استنادًا .الطبي الفريق أعضاء مع الفور على النتائج
 غير عدد  وتقدير ملصقات  بدون الكهربائية الهوية لتحديد  األساس بناء نحو انطالق نقطة بمثابة
 .النانوية  الجزيئات  من محدود 
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Chapter 1: Introduction 
Many diseases can be detected and identified by conventional urine tests together with 
the label-free techniques employing capacitance–voltage plots, to identify 
abnormalities in the urine. Enhanced methods are always needed to address the 
demands of biomedical engineering advancement. In the research for comprehensive 
knowledge of the human body, urine always plays a key role. 
1.1 Motivation 
Globally, the number of deaths per year caused by kidney disease is increasing at a 
very fast pace, with a rate even higher than that of breast cancer, heart failure, prostate 
cancer, diabetes, etc. [1]. Kidney diseases are silent in the initial stage and do not 
initially reveal prominent symptoms, thus resulting in delayed diagnosis. These 
diseases cannot be detected until they become severe, but basic tests of urine can help 
analyze symptoms of any form of kidney ailments. 
Urine, which contains an immense amount of information related to its physical, 
chemical, and biological components, is secreted by the kidneys and excreted through 
the urethra [2]. Urine is widely used as a biomarker for the early recognition of liver 
and kidney malfunction. The typical chemical composition of urine contains 
approximately 95% water and 5% nitrogenous molecules, such as urea, chloride, 
sodium, potassium, creatinine, and other dissolved ions. Moreover, organic and 
inorganic compounds such as proteins, hormones, and metabolites, in addition to other 
metabolic waste components, are also includes in urine composition [3].  
Available laboratory analysis techniques for renal problems are depicted in Figure 1.1. 





composition of renal calculi, implying that a combination of aforementioned methods 
is required for analysis [4, 5]. There are several conditions that can cause atypical 
components to be excreted in urine, such as proteinuria (a high protein content due to 
abnormal glomeruli), oliguria (a much lower amount of urine excretion, generally 
caused by kidney damage), polyuria (a very large amount of urine excretion, usually 
caused by diabetes), dysuria (regular painful urination due to urinary tract infections, 
UTIs), hematuria (red blood cells, RBCs, present in urine, often due to infection or 
injury), and glycosuria (excess plasma glucose because of diabetes) [3]. Thus, 
urinalysis provides crucial data for monitoring individual health and disease states. 
This field mainly focuses on disease detection at the initial stage [2]. 
 







1.2 Research Significance and Objectives 
The evolution of kidney diseases can be slowed by early detection and treatment, 
which is the focus of the study. Hence, the early diagnosis of diseases requires 
subsequent steps of disease treatment, prevention, and management that might even 
involve curing the disease. This study is intended to help improve healthcare 
techniques so that individuals can monitor their health by using their urine samples 
while engaging in normal activities.  
The primary research objectives of this study are to introduce label-free, noninvasive, 
fast and reliable techniques for aberrations in the urine and to develop a simple clinical 
tool to predict the likelihood of developing kidney disorder in conjunction with 
characterizing biotic materials’ peculiarities in this context. These goals can be 
achieved by detection, identification, and quantification of various types of 
abnormalities in urine using electrical and validation using the same, as mentioned in 
Figure 1.2. 
 






1.3 Rationale  
The electrical attributes of urine can provide enhanced comprehension regarding 
various clinical aspects. Numerous studies have been conducted to determine the 
disparities of normal urine. For instance, variations in the dielectric properties of urine 
samples can be used to determine different stages of breast cancer [4, 5]. Using the 
electrical impedance, a significant difference was observed between the mean 
impedance of normal urine and urine containing higher numbers of RBCs and white 
blood cells (WBCs) or other constituents [6, 7]. 
Moreover, the electrical conductivity and total dissolved solids are correlated; any 
change in the concentration of cells and other components in urine can easily cause a 
change in electrical conductivity [8, 9]. Various capacitive sensors are available to 
detect UTIs [10, 11]. Furthermore, urine components such as protein and glucose can 
be detected through microfluidic technology [12–14]. Kidney stones can be detected 
using the electrical conductivity and dielectric properties [15, 16]. 
1.3.1 Kidney Stones in Urine 
The presence of renal stones is a typical disorder, with a predictable recurrence rate of 
five years in 50% of the cases. Kidney calculi have no specific origin but numerous 
factors that sharply increase the risk. Lithiasis occurs when the urine becomes 
concentrated and contains an excess of crystal-forming elements, such as uric acid 
calcium, oxalate, etc. Concurrently, urine can be deficient in substances that prevent 
crystals from aggregating. The identification of kidney stones can also be performed 
based on their various properties. Knowing the type helps in determining the source 





Due to the continuous change in dietary proclivity and lifestyle, there has been a steady 
growth in the susceptibility to calculi over the past decades, as shown in Figure 1.3. 
Most kidney stones are of calcium type, typically in the form of calcium oxalate, which 
is highly prevalent. Oxalate is a naturally existing substance that is found in various 
food items and produced by the liver on a daily basis. Calcium oxalate is a calcium 
salt of dicarboxylic acid and oxalic acid that occurs as a dihydrate or monohydrate, 
i.e., calcium whewellite and weddellite, respectively. Certain types of chocolate, nuts, 
vegetables, and fruits have high oxalate quantities. Dietary proclivity and lifestyle 
along with heavy doses of vitamin D, certain surgeries and several metabolic disorders 
can enhance the concentration of calcium oxalate in urine. 
 





Calcium phosphate is an additional type of calcium calculus found in metabolic 
problems such as renal tubular acidosis. Moreover, these problems are usually 
correlated with migraine headaches and seizure medications. Struvite stones form in 
reaction to an infection, for instance, a UTI. These stones can grow quickly, without 
any visible symptoms. Uric acid stones form from a lack of fluid intake in the diet or 
in cases where a person loses too much fluid. Certain genetic factors (cystinuria), a 
high protein intake or even gout can increase the risk of uric acid stones. 
Many factors increase the risk of developing kidney stones, such as hereditary aspects 
in people who have a genetic proclivity to developing stones, not drinking enough 
water daily, living in warm climates, which leads to heavy sweating, and having a diet 
that is high in protein, salt, and sugar. A high salt intake increases the amount of 
calcium that the kidneys must filter and significantly increases the risk. Additionally, 
a high body mass index (BMI), intestinal surgery, inflammatory bowel disease and 
diarrhea affect the digestive process and disturb the absorption of calcium and water, 
enhancing the concentrations of stone-forming elements in urine. 
1.3.2 Blood in Urine 
Hematuria is a condition in which blood cells to leak into the urine from the kidneys 
or any other parts of the urinary tract. Many reasons are there for this leakage, such as 
UTIs, stones, enlarged prostate glands, and glomerulonephritis. A quantity of three or 
more RBCs per high-power field (HPF) is considered an abnormal finding. Hematuria 
can be of two types: gross and microscopic, as mentioned in Figure 1.4. The type is 
considered gross when the color of blood is visible in the urine sample and microscopic 






In gross hematuria, depending on the source of the blood, the urine color can range 
from light pink to dark brown. A light-colored shade usually arises because of a lower 
urinary tract problem, while dark-colored shades are due to a glomerular origin. Gross 
hematuria is caused by UTIs, ureteral irritations, congenital abnormalities, 
coagulopathy tumors, acute nephritis, etc. Microscopic hematuria occurs due to 
disorders such as hereditary hematuria, sickle cell trait or anemia, alport syndrome, 
and IgA vasculitis. The various types of hematuria have different etiologies, but in 
some cases, they share common causes. 
 
Figure 1.4: Types of hematuria: a) microscopic hematuria and b) gross hematuria. 
Blood in the urine can be due to many factors. UTIs happen when microorganisms 
enter the body via the urethra and grow inside the bladder. Sometimes the only sign of 
sickness is a microscopic presence of blood cells in the urine sample. Kidney infections 
happen when microorganisms reach kidneys either from the bloodstream or the ureter. 
Stone formation occurs when crystal-forming minerals are present in concentrated 





hematuria. Prostate gland enlargement often occurs in men approaching middle age. 
The effects include squeezing of the urethra, somewhat blocking the urine flow. 
Glomerulonephritis, an infection in the kidney filtering system, either occur by itself 
or can be the part of a systemic disease such as diabetes. It is caused by viral infections, 
vasculitis, IgA nephropathy, etc.  
Advanced renal, prostate or bladder cancer may lead to visible bleeding in urine, which 
is mostly detectable at later stages, when these cancers are less curable. Alport 
syndrome also disturbs the filtering membranes in the kidney glomeruli. Congenital 
disorders such as sickle cell anemia, a hemoglobin defect in the RBCs, causes both 
gross and microscopic hematuria. Kidney injury due to accident can cause evident 
blood in the urine. Furthermore, medications like cyclophosphamide and penicillin, 
along with anticoagulants such as aspirin and the blood thinner heparin, can cause the 
bladder to bleed.  
Hematuria may be a sign of kidney damage or may lead to kidney damage, such as 
hemoglobinuria-induced tubular injury. The presence of metabolites released by RBCs 
in the lumen of nephron tubules can initiate a cascade of intracellular reactions, leading 
to the generation of reactive oxygen species and consequently lipid peroxidation 
caspase activation and eventually programmed cell death (apoptosis). Thus, hematuria 
can act as a diagnostic factor for the presence of kidney disease and as a prognostic 
marker for chronic kidney disease (CKD). Gross hematuria is more frequent at the 
early stages of the disease, while micro-hematuria is associated with worse renal 
outcomes and a higher incidence of patients with end-stage renal disease (ESRD). All 
of these results suggests that detecting microscopic haematuria is critical to predicting 





professionals to take proactive measures to stop initial stages of CKD from progressing 
to ESRD. 
1.3.3 Cells in Urine 
Cells are counted as the number observed per low power field (LPF) or per high power 
field (HPF) or as few, moderate, or many. A disadvantage of this method is that the   
examination of the urinary sediments should be done by nephrologist to provide more 
comprehensive information. Urinalysis mostly consists of analysis by dipsticks, in 
certain cases, it is followed by microscopy of urine sediments. Urinary flow-
cytometers (UFC) are used for better count and accuracy, but the absence of a reference 
measurement is shortcoming for this method.  
Cystoscopy examination is a standard procedure in the evaluation of lower urinary 
tract diseases but is invasive in nature. Several molecular techniques like immunocyte 
use the immunocyte fluorescence technique (using a fluorochrome to indicate an 
antigen-antibody reaction), which employs three antibodies to detect cellular markers 
of bladder cancer using exfoliated cells from urine. However, these techniques are 
costly and lengthy and are not appropriate for routine identification. Diseases such as 
UTI that are caused by bacteria are confirmed by culture methods and WBC counts. 
A combination of various methods can result in higher diagnostic efficiency and 
improved precision. A microscopic examination (which was introduced into clinical 
practice in the 1900s) is part of the routine urinalysis conducted when findings in the 
physical or chemical examination are not normal. This lengthy process is generally 






The aim of the study is to provide a precautionary measure for kidney ailments, 
especially for patients who cannot avail themselves of expensive healthcare 
technology. The study emphasizes improving the current situation of lacking a single, 
fast, non-invasive and comprehensive method. All other techniques require 
preprocessing steps, while the proposed technique can be directly used. The idea 
behind the research is to develop electrical models of urine, treating urine as a medium 
with a variety of abnormal particles in it, to detect these abnormalities, as depicted in 
Figure 1.5. The abnormal particles can be renal cells, blood cells, kidney stones, etc. 
 






1.5 Dissertation Organization 
This dissertation is organized as follows: 
Chapter 1 (Introduction): This chapter introduces the main objective of the thesis along 
with the scope, significance, and motivation. Furthermore, it briefly explains the 
rationale behind this topic. 
Chapter 2 (Electrical Characterization Techniques): This chapter summarizes the 
relevant studies that have been conducted in this field on various biotic materials such 
as DNA, viruses, cells. Highlights of urinalysis along with comparison of various 
available electrical characterization techniques has been done in this section. 
Chapter 3 (Fundamentals of Electrical Properties of cells): This chapter summarizes 
the fundamental theory of electrical characterization of biological cells and discusses 
the various electrical properties related to it. Moreover, modelling of dielectric 
properties of cells and mixture theory has been explained. 
Chapter 4 (Electrical Detection of Blood Cells in Urine): This chapter discusses the 
results of the proposed approach along with the methodology, related with Hematuria.  
Chapter 5 (Electrical Characterization of Calcium Oxalate in Urine): This chapter 
reports the results obtained from performing the experiments on calcium oxalate in 
urine, along with the processing and discussion of the results. 
Chapter 6 (Conclusions and Future Work): This chapter summarizes the research 
findings and relates them to the objectives presented in the first chapter, in addition to 





Chapter 2: Electrical Characterization Techniques 
Electrical characterization is a technique used to apply an electrical framework to 
various materials. The electrical properties of a material are built on the basic elements 
that are atoms. For illustration, the number of electrons in a material, their 
arrangement, their movements, and whether they become ionized when exposed to 
external factors such as photons, temperature, and an electric field are all related to the 
electrical properties of the material. Hence, every living and nonliving material 
exhibits electrical properties such as resistivity, electrical conductivity, and 
permittivity. These electrical properties of dielectric materials are obtained to enable 
their electrical characterization. 
2.1 Why to use Electrical Characterization? 
The electrical characterization of biological materials has been gaining popularity for 
several decades. The world is approaching the microelectronic and nanoelectronics 
era. With the progression of CMOS, MEMS, BioMEMS and other technologies, the 
popularity of this field has surged. The miniaturization of large and heavy devices is 
made possible through developments in the field of electronics. For building smaller 
electronic devices and gadgets, electrical characterization of materials plays a pivotal 
role. Thus, this tool has become a crucial technique in numerous fields, such as 
medical, science and engineering. Apart from the miniaturization aspects, the analysis 
of electrical equivalent circuits can be carried out in both the domains of time and 
frequency by making use of various tools, such as the Fourier transform, Z-transform, 






2.2 Electrical Characterization of Biotic Materials 
The new advances in the biomedical and health field are developing in great leaps. In 
this section, a generalized description of the famous trends in the biomedical field is 
presented. The review includes the electrical detection and identification of 
undesirable or pathological biotic materials. 
2.2.1 Electrical Characterization of DNA 
DNA is the source of the traits of all living creatures and is required to balance the 
homeostasis of life [17]. An extensive variety of biotic process research requires an 
understanding of the basic electrical properties of DNA, such as restoring impaired cell 
bonds, identifying genetic alterations, and characterizing the links between proteins and 
DNA [18]. Various electrical-based DNA characterization techniques have been 
studied, such as the use of carbon nanoparticles (CNPs) [19–21], field effect transistors 
(FET) [22, 23], cyclic voltammetry [24, 25], molecular wires [26, 27], graphene 
quantum dots [28, 29], and dielectrophoresis [30, 31]. 
2.2.2 Electrical Characterization of Viruses 
Viruses are microscopic creatures that may induce mild to severe ailments in humans, 
animals, and plants [32]. These diseases may range from the common flu or cold to 
fatal diseases. The virus element attacks the cells and controls their mechanism for its 
own survival and to proliferate and spread. Thus, the contaminated cell generates viral 
products instead of its usual ones [33]. There are many fatal viruses, such as HIV, 
dengue, enterovirus, norovirus, and many more. Several techniques are available to 





nanotechnology [35], carbon nanotube networks [36, 37], microstrip cavity resonant 
measurement [38], and dielectrophoretic impedance measurement (DEPIM) [39, 40]. 
2.2.3 Electrical Characterization of Cells 
The study of various kinds of cells has developed as a diverse new domain and is 
recognized as one of the fundamentals in the medical field. Cells have distinctive 
physical and chemical properties to sustain them within their environment to complete 
their explicit functions [41]. Moreover, the biophysical properties of cells provide 
critical information, especially the characterization of cells based on their electrical, 
mechanical, optical and thermal properties [42]. These properties give early 
indications of sickness or an atypical state of the body, offering promising markers for 
detecting various cancers [43–47], bacteria [11, 48–51], toxins [52, 53] and tissue 
status [54–56]. Fast-emerging technologies have been developed and advanced by 
scientists in the past few decades to study the biophysical traits of cells, applying 
extensive influences to biology and the clinical research field, especially in the area of 
microfluidics [45, 57, 58]. 
2.2.3.1 Single-cell Analysis  
Single-cell analysis (SCA) is a significant subject to engineers and scientists in the 
area of biomedical engineering to develop the available experimental tools and 
technologies for single-cell characterization [59, 60]. For example, complex analysis 
and detailed investigation of the differentiation between normal and cancerous cells 
can be achieved only with the help of SCA [61]. In conventional approaches, 
population-based procedures have been used, such as cell growth, proliferation, 
metabolism and motility. These procedures use average values of the cell traits to 





technique can present erroneous results and usually omits crucial data due to mixture 
of various cells [63]. Hence, single-cell researches offers to explore the molecular 
structure of distinct cells. SCA is important in determining treatment plans for cancer 
patients [64].   
Electrical traits of cells offer rigorous data about complicated physiological states. 
Cells which undergo aberrations or have been contaminated by microorganisms, 
exhibits altered ion channel movement [65], cytoplasm conductivity and resistance 
[66–69] and deformability [70]. Such as, RBCs tainted by Plasmodium falciparum, 
exhibit reduced deformability [46, 71, 72]. The disease-altered RBCs undergo a 
change in resistivity, moreover, the normal RBCs and rigidified RBCs have 14.2 and 
19.6 Ω of average resistance, respectively [71]. The electrical traits of cells are 
beneficial in counting, separating, trapping and characterizing a single cell. 
a) Conventional Techniques 
The conventional technique to analyze cell electrical properties was initiated in 1791 
by measuring the electrical activity in animals by electrical stimulation with metal 
wires [73]. Over the years, the tools for electrical characterization have been improved. 
The classical techniques, such as patch clamps and probing, are quite promising for 
electrical property characterization of a single cell. 
i)   Patch Clamp 
This technique supports the high-resolution of the ionic currents in the cell membrane. 
Neher and Sakmann in 1976 introduced the patch-clamp technique; since then, the 
patch clamp has been used by scientists for crucial data regarding the electrical traits 





to create a high electrical resistance between 10 and 100 GΩ, known as giga-seals [77]. 
Then, the ion current which flows through the electrode of the pipette, is measured via 
an amplifier. 
 
Figure 2.1: The principle of patch-clamp measurements [78]. 
In Figure 2.1, a pipette comprising an electrolytic mixer is firmly inserted into the 
membrane, electrically isolating the membrane patch. A current (X+) flows via the 
passage in the patch, which helps in measuring the flow into the pipette using an 
electrode. The electrode is linked to a differential amplifier. The overall configuration 
of the voltage clamp includes a current which is applied inside the cell through 
negative feedback (using a resistor) to compensate for variations in the voltage of the 






This method has following drawbacks: 
• It is time consuming [79–84]. The complete cell population has to be changed 
after the extra-cellular fluid has been used.  
• The quality and condition of the cells along with their suspension should retain 
certain properties for homogenous channel measurements [62].  
• Experienced researcher is essential to move the glass pipette without harming 
the cell.  
Further concerns are the recording quality and heat control. However, the patch-clamp 
gives high sensitivity and low-noise measurement of the currents [73-85]. 
ii)  Nanoprobes 
 





Nanoprobes can be used for single-cell electrical characterization. Nanoprobes are 
well suited for measuring the electrical features of cells and statistically determining 
their capabilities, as shown in Figure 2.2. Some studies have established dual 
nanoprobes combined with nanomanipulators within an environmental scanning 
electron microscope (ESEM) to achieve electrical penetration of single cells [86].  
ESEMs can be utilized for high-resolution while maintaining the cell’s natural state 
[87]. This method has been used to effectively differentiate live and dead yeast cells 
based on their electrical properties [86]. Recently, for high precision and 
reproducibility, electrostatic force microscopy (EFM) has been used to calculate the 
electric polarization of single bacterial cells [88].  
Generated topographic images helps in acquiring the geometry and finite-element 
numerical models of bacteria to calculate the dielectric constants of the cell [88]. The 
complete method requires a large apparatus that can be implemented only in an 
environmentally controlled area, for instance, a clean room [89]. 
b) Advanced Techniques 
The development of microfabrication procedures, such as soft lithography, opens new 
prospects for economical and rapid manufacturing of micrometer-size structures [90]. 
i)   Microfluidic Systems 
Rapid advancements in microfluidic systems have been observed, both for biology and 
medical investigations [91]. Microfluidic structures are used to study materials at the 
millimeter scale in microscale fluidic passages. Microfluidic structures known as 
micro total analysis systems (µTASs) [92] or lab on a chip (LoC) devices offer the 





Microfluidic systems are broadly implemented in modern clinical studies. For 
instance, DNA [93] and cellular analysis [94] is reproducible, requires little power 
usage and reagent consumption, is cost effective and open to modifications and can be 
combined with the other technologies [95, 96]. The capability of microfluidic methods 
to detect initial stage cancer and handle complications in its review which allows it to 
switch conventional methods in electrical SCA.  
Various microfluidic methods have been established for studying the electrical 
constraints of the cell, such as Micro-electrical impedance spectroscopy (µEIS), 
electrorotation (ROT), and impedance flow cytometry. Some of these techniques are 
shown in Figure 2.3. 
ii)  Electrorotation 
A cell rotates when placed in a revolving electric field (E⃗ ) in a medium that itself has 
a nonuniform E⃗  field. This ROT generally helps in determining the dielectric 
constraints of cells. The ROT concept is centered on the revolution speed of cells per 
unit particle by considering the frequency of a rotational field E⃗ . The E⃗  is produced 
through four electrodes which are linked to ac signal with a ninety degree out of phase 







































































































































































Figure 2.4: Illustration of the working principle of ROT. 
The cross-connection of quad-electrodes is set to get sine wave 90○ apart, which is 
chief in ROT technique [98–100]. Figure 2.4 depicts the working principle of ROT 
where probes fed by an ac signal generator creating a revolving E⃗ . The E⃗  pulls the cell 
into the middle of the setup and then rotates it in a direction either similar to or opposite 
that of the rotating field [101]. The dielectric properties of the cell can be deduced 
using Maxwell’s theory which correlates cell’s complex permittivity with its 
suspension [81]. The theory description and ROT working principle can be found in 
numerous articles [102–104] and books [105]. 
In this setup, the electric field magnitude is not affected by the cells, as they are rotating 
only at a certain site within the electric field [54, 106]. Therefore, a suitable frequency 
is within the range of 1 kHz up to 200 MHz to identify characteristics such as the 
cytoplasm conductivity and permittivity along with the membrane capacitance [107, 





dielectric properties of leukocytes in cell combinations. Moreover, ROT was applied 
to obtain practical cell information in real-time calculations [109, 110]. Dalton proved 
that ROT resolved the viability of intestinal parasites [111].  
2.2.3.2 Electrical Detection of Cancer Cells 
There are numerous types of cells that can be detected electrically. The main idea 
behind this method is to detect abnormalities inside the human body. The atypical 
presence of cells in body fluids can be used to indicate any of several diseases. The 
cells might be normal, cancerous or tumorous, depending upon the stage of the disease. 
The most crucial cells to detect are cancer cells. The following sections describe 
several techniques used to detect cancer. 
a) X-ray Mammography 
It employs electromagnetic radiation to detect early stage cancer in a controlled 
manner (else it can exaggerate cancer due to the ionizing nature at high frequencies). 
The total dose for a screening mammogram for both breasts is approximately 0.4 mSv 
[112, 113].  
An X-ray Imaging setup has been shown in Figure 2.5. The proportionality of X-ray 
transmission energy is inversely with wavelength and directly with transmission 
frequency. Therefore, high-frequency X-rays cause photons of higher energy and 
generate better mammography results. However, the higher the penetrating power, the 
more the ionizing effect of the X-rays is. 
Conventional X-ray mammography cannot maintain a balance between higher 
penetrations or less ionization of low-frequency X-rays while simultaneously 





error rate of X-ray mammography in detecting tumors is quite significant, which 
includes false-positive and false-negative prospects. 
 
Figure 2.5: X-ray imaging setup [114]. 
b) Magnetic Resonance Imaging 
There is a substitute for X-rays, i.e., magnetic resonance imaging (MRI), for detecting 
cancer tumors. MRI offers better sensitivity, but the specificity is quite low and 
sometimes give false-positive results [117], however its frequency range is about 60 
MHz [117]. It generates a powerful magnetic field (from 0.2–3 T), which line up the 
protons of water molecules present inside human body. The protons absorb the energy 
from field and reverse their spins. Protons in different body tissues return to their 
normal spins at diverse rates, so the scanner can differentiate among various types of 






Figure 2.6: The basic setup for MRI [118]. 
The MRI techniques include two types normally used in biomedical imaging: diffusion 
MRI and functional MRI (fMRI). Diffusion MRI focuses on how water molecules 
diffuse in body cells and tissues. This method can easily detect tumors, as tumors are 
relatively impermeable to water molecules. However, fMRI provides images of 
structural and functional activities. In addition, fMRI helps in detecting variations in 
blood flow to various tissues and organs. 
c) Ultrasound Waves 
It is an alternative for sensing and examining the occurrence of tumors. Sound waves 
at high frequency are applied on affected area and the receiver transforms signals into 
images, as shown in Figure 2.7. It is not as effective as mammography or MRI but it 






Figure 2.7: Tumor detection using ultrasound. 
Ultrasound can help characterize the tumor category and is considered a valuable 
extension of manual palpitations to detect the presence of any tumors. Although 
ultrasound waves have frequencies above approximately 20 kHz, they exhibit 
inadequate penetration because their frequency is still lower than that of the MRI and 
X-ray methods [119, 120]. 
d) Positron Emission Tomography (PET) 
It is an imaging technique which classifies malignancy by injecting mixture of 
radioactive materials with sugar, followed by observation of how cells react. Detection 
using PET has been depicted in Figure 2.8. Cancer cells multiplies at quicker rate and 
absorbs more nutrients of the injected mixture. During this process, positrons are 
released, allowing the generation of an image. PET can find initial stage cancer; 
however, it is limited by less resolution. PET can be joined with other procedures, like 






Figure 2.8: Detecting cancer using PET [121]. 
e) Ultra-wideband Techniques 
Microwaves offer improved tumor detection without the danger of ionization effects 
on cells and tissues. Its radar imaging characterizes the power of waves to differentiate 
between normal and abnormal tissues as shown in Figure 2.9. Its pros are power 
efficiency and noise cancellation. As a result, this method is economical for real-time 
body imaging. The main features of UWB are as follows: 
• High penetration 
• High precision 
• Less electromagnetic radiation 
• Less processing energy consumed 
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Figure 2.9: Detecting breast tumors using microwaves [122]. 
2.3 Urinalysis 
2.3.1 Dipstick Test 
This is the most basic method of the urinalysis which still has been used. 
Figure 2.10: Dipstick analysis using testing sticks and comparison with 
standard markings. 
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The dipstick is a plastic stick with strips of various chemicals placed on it, which are 
used to detect abnormalities within a urine sample. The chemical pads vary in color to 
indicate the presence of substances such as blood, bilirubin, urobilinogen, ketone, 
protein, nitrite, glucose, leukocytes, pH level and specific gravity. Figure 2.10 shows 
dipstick analysis and comparisons with standard marking. 
2.3.2 Matrix-assisted Laser Desorption Ionization–Time of Flight Mass 
Spectrometry (MALDI–TOF/MS)  
It is an ionization process in which a matrix (saturated organic solution) is added to 
the sample (a microbial colony or blood, urine, cerebrospinal fluid, or protein extracts), 
after which the concoction is kept on a metallic plate. The matrix helps in ionization 
by providing protons to the sample. The sample and matrix crystallize on the metal 
plate and are targeted by the beam of a UV laser. The irradiation is brief to avoid 
variations in the sample caused by overheating. The contact between the photons of 
the laser and targeted molecules causes the matrix to change into gaseous form, 
followed by sample ionization. A schematic depiction of MALDI–TOF/MS analysis 
techniques for protein has been depicted in Figure 2.11 while for multiple samples in 
Figure 2.12. 
In the case of the urine analysis for UTIs, before using MALDI–TOF/MS, the 
occurrence of bacteria or blood inside the urine sample has to be known, which can 
limit the usefulness of the urinary proteomic analysis [123]. A high bacterial 
concentration in the urine samples improves the likelihood of bacterial detection at the 
expense of not detecting the remaining proteome profile. 
Various studies have shown that it is a good option for the direct recognition of any 
bacteria in urine samples. The reliability is suitable for specimens with bacterial 
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densities up to 103 CFU/mL [124]. Studies have been performed to enhance the 
performance of the methodology and to eliminate leukocytes, proteins and many other 
components for the identification of urinary pathogens [125, 126]. This method avoids 
the requirement of urine culture in complex cases. 
However, MALDI–TOF/MS cannot accurately classify assorted bacteria existing in 
urine samples [125, 127]. Moreover, no consistent procedure currently exists regarding 
the preprocessing of specimens. 
Figure 2.11: A schematic depiction of MALDI–TOF/MS analysis techniques for 
protein. Reprinted with permission from the American Society for Microbiology. 
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Figure 2.12: A schematic depiction of MALDI–TOF/MS analysis techniques 
with multiple sample types. Reprinted with permission from the American 





2.4 Comparison of the Various Techniques  
In this section, comparisons of various available techniques for cell detection and 
their identification, has been discussed. 
2.4.1 Electric Field-based Techniques for Cell Manipulation 
For tissue engineering, various types of electric fields are used for cell manipulation, 
such as electrical, optical [128–131], ultrasound [132, 133] and magnetic [134, 135], 
which are undergoing advancements. The main methods are compared in Table A.1 
[136] (mentioned in Appendix). Physical force field-based methods rely on low-
conductivity buffers to be fully operative, as opposed to other methods that work 
directly in the growth medium. Methods based on an electric field lack spatial 
resolution, but only the electrode array size limits the number of cells that can be 
manipulated.  
In contrast, the laser tweezer methods are fundamentally limited by their spatial 
resolution, and the number of manipulated cells is also very limited. Ultrasound-
based methods are also subject to significant spatial resolution limitations. One of 
the main disadvantages of magnetic methods is that cells are not usually 
magnetizable. Hence, the cells are forced to take up paramagnetic materials. This 
alteration is not required by the other approaches. 
2.4.2 Characterization of Nanomaterials 
The preparation of nanomaterials requires approaches for their crystal structure, 
shape and size, chemical alignment, energy levels and dynamics of chemical and 





discussed to evaluate their shortcomings at the nano-level, as shown in Table A.2-
A.5 [137], mentioned in Appendix. 
2.4.3 Cancer-detecting Methods and their Modalities 
Cancer-detecting methods and their modalities are compared in Table A.6 (mentioned 
in Appendix), which indicates that despite their capability to find tumors, these 
methods still lack various capabilities. The erroneous result rates are quite significant. 
False-positive results lead to several unnecessary additional tests, while false-negative 
results miss tumors at the initial stage that could lead to cancer growing and spreading 
throughout the body. Sometimes the difference in the parameter of interest between 






Chapter 3: Fundamentals of the Electrical Properties of Cells 
3.1 History  
The electrical-based passive properties of cells were first scientifically investigated in the 
1770s by Henry [138], who found that the current was directly proportional to the voltage 
and that salt mixtures showed greater conductivity than normal water. The famous 
relationship connecting the voltage, current, and resistance was given by Georg Ohm, 
who formulated the well-known Ohm’s law [139]. In 1902, Bernstein [140] combined all 
of the relevant information about the cell membrane and articulated certain features. First, 
cells have an electrolyte enclosed by an impermeable membrane that allows the flow of 
ions. Second, a steady-state potential difference exists across the membrane. Third, the 
membrane allows potassium ion flow over a certain range of currents and voltages, 
known as the Nernst diffusion potential. Fourth, living tissue exhibits a relatively high dc 
resistivity. 
Höber [141, 142] deduced that at different frequencies, the current path changes; he 
focused mainly on the current penetration into the conductive part of the cell at higher 
frequencies. He also developed the concept of 𝛽-dispersion, which describes the 
phenomenon that the outer membrane of the cell has a high resistivity for dc and (low-
frequency) ac currents and has a very high capacity for collecting ions at its surface, 
which is known as Maxwell–Wagner interfacial polarization. 
Various equivalent circuits have been proposed by many scientists. Figure 3.1(a) shows 
the equivalent circuit of RBCs developed by Philippson [143], where R and r are the 
resistances of the cytoplasm and membrane, respectively, while C is the capacitance of 





circuit of RBC suspensions, where R0 is the resistance around the cell and Ri is the 
resistance of the cytoplasm [144]. Cole and Baker discovered an inductive reactance 
within the membrane structure [145] and developed the equivalent circuit depicted in 
Figure 3.1(c). The resistance and capacitance of the cell can be measured by a parameter 
(𝜙) that signifies the ratio of the actual area of the cell membrane to the area of the 
membrane (4𝜋r2) formed by smooth and spherical layers of the cytoplasm or nucleoplasm 
[146]. The calculated membrane capacitance (Cm) and membrane resistance (Rm) are: 





=                                                          (3.2) 
where Co and Ro are the values associated to 𝜙=1. 
 
            (a)                                            (b)                                                      (c) 
Figure 3.1: Equivalent circuits proposed by (a) Philippson, (b) Fricke and Morse, and 





3.2 Electrical Properties of Cells 
There are various electrical properties related to biological cells that not only help in 
better understanding the characteristics of cells but also help acquire indications about 
the abnormalities within them. Some of the electrical properties are the dielectric 
dispersions (α, β, γ, and δ dispersions), polarization (electronic, atomic and orientation 
polarization), and relaxation (static and dynamic permittivity). These aspects are 
explained as follows: 
3.2.1 Dielectric Dispersions 
The dielectric properties of the cells at the cellular and molecular levels can be 
determined by the interaction of EM radiation. The relative permittivity (εr) can reach 
up to 106 to 107 below 100 Hz. The permittivity variation at high frequencies can be 
described via the so-called α, β, γ, and δ dispersions [147]. The dispersions indicate 
the dielectric relaxations that arise from the polarization mechanisms that occur in 
complex biological environments. 
 





The step changes in relative permittivity (εr) over the frequency spectrum are called 
dispersions and are often occurs because of the loss of certain type of polarization 
modes, as depicted in Figure 3.2. The α, β, γ, and δ dispersions consequently are 
described by the dielectric relaxation and frequency range and mainly by the total 
dielectric decrements, i.e.,  ,  ,   and  , respectively. 
a) α-dispersion 
α dispersion occurs in a low-frequency range, i.e., 10 Hz–10 kHz, while the relaxation 
time (τ) is 6 ms. This mode is categorized by a very high permittivity increment and 
very high dielectric decrement values (
610  ). This dispersion occurs near the cell 
membrane where the movements of charged particles are limited. The cell membrane 
is a complex structure consisting of phospholipids, cholesterol, proteins, and 
carbohydrates. There is a potential difference (approximately 60–70 mV) between the 
intracellular and extracellular media due to the ions which is distributed around the 
membrane (about 10 kV/mm). The phospholipids and cholesterol maintain the fluidity 
of the cell membrane whole proteins help in ion and signal transport. Penetration into 
the membrane is possible from the ion channels and membrane-spanning protein. 
However, the change in conductivity is about 5 mS/m for a 106-permittivity increment, 
with a relaxation frequency of 100 Hz [148-150]. This shows that with a large 
permittivity increment, there is very small corresponding conductivity decrement. 
b) β-dispersion 
It arises within the frequency range of 10 kHz–10 MHz with a relaxation time of about 
approximately 300 ns. The cellular membranes and other intracellular bodies become 





electrically shorted, while the current can penetrate through the cytoplasm. This 
penetration decreases the impedance and leads to the β-dispersion or interfacial 
polarization or the Maxwell–Wagner relation. This effect occurs at the interface of 
membrane-electrolyte structures, which have two different dielectrics, leading to the 
formation of charges. 
The polarization magnitude depends on the conductivity, permittivity, and structure of 
the distinct intracellular components. With increasing frequency, the number of 
resistive elements is nullified by their related parallel capacitances, making the 
intracellular structures more electrically similar. Usually, blood shows interfacial 
polarization at the 3 MHz frequency with a 50 ns relaxation time and 2000  . 
This arises due to charging cell membranes through the electrically conductive 
cytoplasm cell. The effect is an extension of β-dispersion and hence is called β1-
dispersion [151]. Certain tissues have larger cell sizes and hence exhibit larger 
permittivity values than those of blood. 
c) δ-dispersion 
Some protein solutions exhibit δ-dispersion, which lies between the β and γ 
dispersions. If present, the effect falls in the range of 0.1 to 5 GHz, and comparatively, 
its magnitude is small. δ-dispersion was first categorized in a study by Pethig [152] 
and was credited to the dipolar moments of proteins and other large molecules such as 
biopolymers, cellular organelles [153] and protein-bound water [154]. The total water 
content of tissue consists of free water and the bound water. The bound water is 
rotationally hindered and has a relaxation frequency lower than that of the free water 






In 1989, Foster and Schwan discovered γ-dispersion [155], which occurs due to the 
presence of water content in the cells and tissues. The dielectric properties of cells and 
tissues at frequencies above 0.1 GHz depend on the intracellular electrolytes and water 
(dipole polarization). At frequencies above a few hundred megahertz, the complex 
permittivity can be decoupled into a Cole-Cole term and a conductivity term, 
corresponding to the dipolar dispersion of water and the electrolytic behavior, 

















                           (3.3) 
where σ is the conductivity from ionic currents and low-frequency polarization and α 
is the distribution parameter. γ-dispersion arises at microwave frequencies of 
approximately 25 GHz with a relaxation-time of approximately 6 ps and dielectric 
decrement of  ≈50.  
3.2.2 Polarization 
Polarization is a process that occurs when a field E is employed on a dielectric material 
and the charges start moving within the structure. The amount of charge passing 
through a unit area within the dielectric, perpendicular to the direction of the applied 
field E, is called the polarization. The three types of polarization [156] are as follows: 
a) Electronic Polarization (Pe): As the name suggests, electronic polarization occurs 





atoms in the dielectric material. The duration of the phenomenon is very small (⁓10-15 
s), which corresponds to the period of ultraviolet light. 
b) Atomic Polarization (Pa): Atomic polarization occurs due to the shifting of atoms 
or groups of atoms within the structure. The duration of the phenomenon corresponds 
to the period of infrared light. 
c) Orientation Polarization (Po): Orientation polarization arises from polar molecules. 
It occurs in dielectric materials because of the rotation of permanent dipoles. The 
orientation of molecular dipoles occurs in the path of the applied field and depends on 
the molecule size, viscosity, temperature, and applied field frequency. The duration of 
the phenomenon corresponds to the period of the microwave frequency region. Thus, 
the overall polarization (Pt) is: 
      t e a oP P P P= + +                                   (3.4) 
Therefore, polar materials have a higher dielectric permittivity than nonpolar materials 
because of the presence of additional polarization due to orientation. 
3.2.3 Dielectric Relaxation 
The theories of dielectric relaxation are based on static permittivity and dynamic 
permittivity: 
a) Static Permittivity: When a dielectric material has a constant dipole, the moment is 
placed in a steady electric field so that all types of polarization can maintain 






b) Dynamic Permittivity: With the change in the frequency of the applied field, the 
frequency-dependent permittivity of the dielectric material is called the dynamic 
permittivity [158]. 
3.2.3.1 Static Permittivity and Its Models 
Different models are used to describe the static permittivity, some of which are 
described below: 
a) Clausius–Mossotti Relation 
The Clausius–Mossotti relation expresses the permittivity in terms of the atomic 
polarizability [159]. Under the influence of an electric field (F) acting on a molecule, 
the molecules possess an electric moment (m): 
0m F=                                                    (3.5) 
where αo is the polarizability of each molecule. The dipole moment may be permanent 
or induced. The average moment ( M ) in the path of the field is the average dipole 
moment and the displacement of elastically bound charges [160]: 
2 2cos
.M F e r
KT
 
= +                                      (3.6) 
The force F applies a unit positive charge bounded by a small sphere [161]. This force 
consists of three components: one related to the surface charge density (δ) of the plates 
(F1), one related to external surface polarization (F2) and one related to molecules 
inside the small sphere (F3). 





1 4F =                                              (3.8) 
F2 has been divided two parts, the first due to conducting plates and the second due to 
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                                           (3.9)  
where P is the polarization of the medium. A general expression for F3 is used in 
special cases; in a cubic crystal, however, F3=0. The total force F is: 
( )4 4 4 / 3F P P  = − +                                    (3.10) 
However, the dielectric displacement is 4 4D E P = + = : 
( )4 4 4 / 3F E P P P  = + − +                             (3.11) 
( )4 / 3F E P= +                                            (3.12) 
Moreover, the dielectric displacement can be represented as: 
( )4D E E P = = +                                       (3.13) 
 ( ) ( )1 4 / 3E P − =                                        (3.14) 










This relation expresses the coupling between the actual force and electric field from 
the electrostatic calculations [162]. Let N1 is the number of molecules/cubic 
centimeter; then polarization is: 










                                      (3.18) 
By using Equations (3.14) and (3.18), the link between the dielectric constant and 
molecular polarizability (αo) is obtained: 
( )
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In pure substances, N1 = Nd / M, where M is the molecular weight, d is the density and 














                                 (3.20) 
This relation is known as the Clausius–Mossotti equation [159, 160]. The RHS of 
Equation (3.20) shows the molar polarization (p), which describes the electric 
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                                       (3.22) 
The permittivity depends on the amount of polarization, which is a function of the 
frequency of the applied field. At increasingly elevated frequencies, there is less 
polarization, and therefore, the permittivity value decreases with increasing frequency. 
b) Debye Theory of Static Permittivity 
To derive the relation for static permittivity, the field at a single molecule is considered 
by imagining a spherical surface of molecular dimension in the dielectric medium. 
Assume that the medium inside the sphere is composed of individual molecules and 
that outside the sphere lies a medium of homogeneous permittivity. The field at the 
center of the sphere can be divided into three parts: first, the external charges and 
applied field; second, the surface polarization charges; and third, the field due to the 
sphere material. 
Debye’s theory depends on the suppositions that no neighboring forces act on the 
dipoles and that the field component due to molecules inside the spherical region is 


















                                (3.23) 
where N1 is the number of molecules per unit volume, α is the polarizability (α = 
αelectronic + αatomic), µ is the dipole moment, K is the Boltzmann constant, εo is the static 





M and density p, then 1 /PN N M= , where N is Avogadro’s number. Therefore, 
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 is called the molar polarization. 
The following inferences have been obtained from Debye’s theory [163]. First, for 
non-polar substances, the polarizability must be constant and unaffected by the 
temperature and pressure. The density is directly proportional to the permittivity. 
Second, in the case of polar materials, the dipolar polarization decreases due to thermal 
agitation. Third, below a certain temperature (T), the polarization becomes quite large, 








=                                               (3.25) 
Some limitations in Equation (3.23) arise because of assumptions made to derive the 
Debye relation. As the validity of the equation is restricted to fluids due to first 
assumptions, it is not applicable to crystal materials. According to the Debye relation 
and  Equation  (3.25), liquids act as ferroelectric materials at T < Tc (where the molar 
polarizability tends to /M p at 0 → ), but ferroelectricity is quite uncommon. This 
failure of the Debye equation is due to the statement that the medium force inside the 






c) Kirkwood Theory 
Kirkwood considered a material specimen with N dipoles, each having moment µ, 
within a sphere of volume V inside a uniform external field. Using this assumption, 
Kirkwood developed an equation for non-polarizable dipoles: 











=                       (3.26) 
where g is a correlation parameter. Further, Kirkwood incorporated distortion 
polarization by attaching the polarizability (α) of each dipole. Thus, Kirkwood’s 
equation is written as: 
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d) Cole Theory 
Cole [162] proposed a theory similar to Kirkwood’s for the static permittivity which 
differs in the behavior of the direction of polarization. He obtained the expression for 
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                      (3.29) 
3.2.3.2 Dynamic Permittivity and its Models 
Various models are used to describe the permittivity in terms of frequency. Some of 





a) The Debye Model 











                                  (3.30) 
where 
* ' "j  = −  is the complex permittivity, ε’ is known as the dielectric 
dispersion, ε” is known as the dielectric loss, ε0 is the static permittivity and   is the 
permittivity at infinite frequency. ω is the angular frequency and τ is the relaxation 
time. The physical significance of these equations is that at the frequency for which 
ωτ « 1, i.e., below the absorption curve, equilibrium occurs in a short time compared 
with that for which the field points in one direction. In this case, the maximum value 
of permittivity is obtained, and little energy is absorbed. When the frequency 
approaches that for which ωτ = 1, the field reverses over a time which makes the 
polarization to reach its maximum value. Thus, the energy absorbed per cycle is 
maximized. At frequencies for which ωτ » 1, there is no significant orientation of 
dipoles in each cycle, and the measured ωτ » 1 permittivity does not contain a 
contribution from this polarization. The dielectric loss approaches zero for small and 
large values of frequencies, while it is maximum for  =1, i.e., ( )( )" 2max 0 / 2n = −  
at a frequency 1/ = , and this parameter falls to half its maximum when
( )( )2 21 / 4  = + . Another way to represent the experimental result is to construct a 
diagram by plotting ε" against ε' at the same frequency. The above equations for ε' and 










   
  
+ −   
− + =   
   
                            (3.31) 











by plotting ε" against ε', a semicircle is obtained, as shown in Figure 3.3(a), called the 
Debye semicircle.  
                       
(a)                                                               (b) 
Figure 3.3: Illustration of (a) the Debye semicircle and (b) a Cole-Cole plot. 
b) The Cole-Cole Model 
It describes the experimental observations of many materials with particularly long-
chain molecules and polymers, which show a broader dispersion curve and the 
maximum loss at lower frequency than would be expected from the Debye 
relationship. According to Cole and Cole [162], in such cases, the permittivity might 
















where 0  ˂1. When α = 0, the above equation reduces to the Debye equation, as 
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3.3 Theoretical Modeling: Maxwell’s Mixture Theory 
The dielectric properties of biological cells that are suspended in media are usually 
defined by Maxwell’s mixture theory [164]. In the frequency domain, this theory gives 
































where mix represents the mixture, p represents the particle, m represents the 
membrane,   is the complex permittivity,   is the permittivity,   is the conductivity,
  is the angular frequency,   is the volume fraction of the cells in the suspension, and 





= −                                                (3.38) 
However, Maxwell’s mixture theory is effective only for low volume fractions, such 
as φ < 10%. Later, Hanai and Koizumi [165, 166] extended the theory for all volume 
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                                  (3.39) 
For the one-shelled model, as depicted in Figure 3.4(a), the complex permittivity of 






























= , mem  is the complex permittivity, i  is cytoplasm permittivity, R is 
cell  radius and d is the membrane width. Thus, cell  depends on the cell size, 
membrane dielectric properties, and internal properties, which are related 
predominantly to the cytoplasm. The complex bio-impedance ( mixZ ) of cells in 










=                                            (3.41) 
where G is a geometric constant ( /G A g= ), A = electrode area and g = gap between 
the electrodes.  
 
(a)                                                                           (b) 
Figure 3.4: Schematic of the (a) one-shell model of a cell; (b) equivalent circuit 
model of a cell in suspension by Foster and Schwan [155]. 
3.3.1 The Equivalent Electrical Model of a Single Cell 
Although analysis of the equivalent circuit model is generally quite intricate, the 
membrane conductivity and the cytoplasm permittivity are usually low [166-167]. 
Simplified expressions are as follows: 
/i ij  = −                                                       (3.42) 





where σi is the cytoplasm conductivity and mem  is the membrane permittivity. 
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                             (3.46) 
By dividing the real and imaginary parts of p  in Equation (3.45): 
2
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The total impedance of suspension comprises the impedance of medium and its cells. 
As described in [155], one cell is equivalent to a cytoplasmic resistance (Ri) in series 

























 =                                        (3.51) 
3.4 Modeling of Dielectric Properties of Cells 
Maxwell noted that to calculate the resistivity of composite matter, the resistivities of 
all particles of the medium should be counted together [168-169]. Later, this model 
was extended by Wagner [171], who demarcated the elements of such materials in 
terms of the complex conductivities. Some of them are mentioned below. 
3.4.1 Permittivity of Cells in Dilute Suspensions 
Consider a field E employed on a fluidic medium (with permittivity 𝜀m) comprising 
suspension of cells, each cell with radius Rc and permittivity 𝜀c. Inside a sphere of 
mixture with radius Rm that comprises n number of cells, then the potential at a distance 
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Now consider another similar sphere where the permittivity of the cells enclosed inside 
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                             (3.56) 
If both spheres have the same dielectric properties, then: 
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                                 (3.57) 
3.4.2 Effective Medium Theory 
3.4.2.1 Mixture Equations by the Maxwell–Wagner Relation 
Equations describing the permittivity and conductivity of cells in a mixture are called 
mixture equations. The measured permittivity value in a dielectric measurement of a 
cell mixture is 𝜀eff. To study the conduction effects in terms of the complex 
permittivity, in Equation (3.57), replace eff and m  by 
*
eff  and 
*
m , respectively. 
* * * *
* * * *2 2
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                                 (3.58) 
Upon rearranging  Equation  (3.58), the effective complex permittivity of the fluid 
medium 
*
m  in the spherical volume is given in terms of the complex permittivity of 
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                             (3.59) 
The expression of complex permittivity and conductivity is as follows [170]: 
* *
0i  =                                      (3.60) 
The above expression Equation (3.60) leads to the same relation 
*
eff  as that defined 
by Wagner [171]. Equation (3.59) describes the average permittivity of the cells in the 
suspension. Assume that 
*
eff  and 
*
m  are approximately equal, then a heterogeneous 
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This equation is called the Maxwell–Wagner equation, which states that if cv  increases 
from zero, then the suspension permittivity rises linearly with the rise in cell 
concentration. To obtain the effective mixture equations, segregate the real and 
imaginary terms of Equation (3.61). The relationships of 
'
eff  and 
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 − =  =                                     (3.66) 
The foundation of effective medium theory is the approximation that states that 
heterogeneous and homogeneous materials are considered equal for a large 
observation scale.  
3.4.2.2 Mixture Equations by Hanai 
Hanai [172] extended the Maxwell–Wagner equation for highly concentrated 
suspensions, which involves gradually increasing the volume fraction cv  in increments 
Δ cv , which increases the mixture permittivity from 
* * *
mix mix mix  → + . The new 










m  changes to 
*
mix . Insert these substitutions into the 
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Integrate the above equation with limits from 0 to vc and 
*
m  to 
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This is called the Hanai mixture equation, and this relationship is typically used to 





3.4.3 Modeling of a Cell 
Cell modeling can be performed on two bases: the single-shell model of the cell and 
the two-shell model of the cell which denotes by the number of membranes. Figure 
3.5 shows both types of cell structure modeling. The basic model of the spherical cell 
does not contain a nucleus or internal organelles. The volume fraction is given by vc 
= (R1/R2)
3 and the following relationship is derived:  
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                               (3.69) 
where the cell radius is R2 and the membrane width d is given by d = R2 − R1. 
 
                           (a)                                                          (b) 
Figure 3.5: Illustration of (a) the one-shell model of a shell. (b) two-shell model. The 
subscripts for the complex permittivity designate the plasma membrane (m), inner 






Figure 3.6: A schematic depicting how to derive the effective complex permittivity 
of a cell in suspension. 
It is inferred that the single-shell model has limitations in describing the dielectric 
properties of the cells completely, as cells contain many organelles itself have 
membranes [173]. The single-shell model considers only the plasma membrane for a 
cell without including the nucleus, whereas the double-layer model includes the 
nuclear envelope of homogeneous membrane [173, 174]. Figure 3.6 schematizes the 
extraction of the effective complex permittivity via Equations (3.59) and (3.69). 
3.5 Chapter Summary 
This chapter deals with the various electrical properties related to biological cells. 
Some of the electrical properties have been discussed, such as the dielectric 
dispersions, which include the α, β, γ, and δ dispersions; polarization and its types, 
such as electronic, atomic and orientation polarization; relaxation with related theories 
and modeling of the static and dynamic permittivity. Maxwell’s mixture theory has 
been explained along with the modeling of the dielectric properties of cells. The 
modeling of cells includes the permittivity of dilute suspensions of cells and the 





Chapter 4: Electrical Detection of Blood Cells in Urine 
Available methods for detecting blood in urine (hematuria) can be problematic since 
the results can be influenced by many factors of patients and in the lab setting, resulting 
in false positive or false negative results. This issue necessitates the development of 
new, accurate and easy-access methods that save time and effort. This study 
demonstrates a label-free and accurate method for detecting the presence of red and 
white blood cells (RBCs and WBCs) in urine by measuring the changes in the 
dielectric properties of urine with increasing concentration of both cell types.  
The current method can detect changes in the electrical properties of fresh urine over 
a short time interval, making this method suitable for detecting changes that cannot be 
recognized by conventional methods. Correcting for these changes enables the 
detection of a minimum cell concentration of 102  RBCs per ml, which is not possible 
with the conventional methods used in the lab except for the semi-quantitative method 
that can detect 50 RBCs per ml; however, this method involves a lengthy and 
complicated procedure that is not suitable for high-volume labs. The ability to detect 
a very small number of both types of cells makes the proposed technique an attractive 
tool for detecting hematuria, the presence of which is indicative of problems in the 
excretory system. 
4.1 Hematuria 
The kidney is a vital organ in the human body with excretory, endocrine and metabolic 
functions [175]. Any abnormalities in or damage to the kidneys can lead to serious 
complications and can be lethal [176]. Chronic kidney disease (CKD) is a term used 





secretion in urine (albuminuria) or decreased kidney function that lasts for more than 
three months [177]. Renal functions are evaluated by estimated glomerular filtration 
rate (eGFR), which is compared to a standardized criterion that aids in determining the 
severity of CKD and thus in stratifying patients. This determination allows for better 
medical interventions and treatments associated with complications, avoiding possible 
progression to end-stage disease. 
The urine of a healthy individual should be clear, with no or very few cells [178]. 
Observation of an increased number of cells in urine can be indicative of a serious 
problem that requires intervention. Hematuria or the existence of RBCs in urine is an 
abnormal condition that might indicate serious kidney problems or can be a sign of 
progression to CKD, if not managed. Thus, accurate detection of hematuria can be of 
high prognostic value, in addition to being important for diagnosis. 
A patient is considered to have hematuria if the number of RBCs is more than five per 
high-powered field (HPF) in microscopy [179]. Under other criteria, even three or 
more cells per HPF are considered an abnormal finding, and this finding should be 
observed in at least two of the sediments of three collected urine samples [180]. 
Hematuria is described as gross/macroscopic when the color of blood is visible to the 
naked eye or as microscopic when the RBCs are few. Microscopic hematuria is only 
detectable by dipsticks or microscopic urinalysis. The two types of hematuria have 
different etiologies, but in some cases, they share common causes. In gross hematuria, 
the urine color can range from pink to red to brown depending on the source of the 
blood. Light colored blood usually comes from the lower urinary tract (non-





The two types of hematuria can be caused by various conditions, such as trauma, 
nephrolithiasis, post infectious glomerulonephritis, and immunoglobulin A (IgA) 
nephropathy. Gross hematuria is also caused by urinary tract infections, perineal and 
ureteral irritations, congenital anomalies, anatomic abnormalities (e.g., tumor), acute 
nephritis, and coagulopathy. Microscopic hematuria, in contrast, can occur in some 
diseases, such as familial hematuria, sickle cell anemia, alport syndrome nephritis and 
henoch-schönlein purpura [181]. Glomerular hematuria is more critical since it implies 
damage to the nephrons that filter the blood that passes through them. The leakage of 
RBCs into the urinary space during glomerular hematuria indicates defects in the 
glomerular basement membrane. These defects can result from abnormalities in the 
structure or composition of the basement membrane in some diseases, leading to 
notches and membrane rupture [182]. Similarly, inflammation or glomerulonephritis 
can also lead to glomerular membrane weakening and leakage as a result of leukocyte 
infiltration into the basement membrane, in addition to the production of reactive 
oxygen species such as H2O2 [179, 183] and proteinases, which damage and degrade 
the components of the membrane, respectively [184]. 
Interestingly, hematuria not only is a sign of kidney damage but also can itself lead to 
kidney damage, such as hemoglobinuria-induced tubular injury [185]. The presence of 
metabolites released by RBCs in the lumen of nephron tubules can initiate a cascade 
of intracellular reactions, leading to the generation of reactive oxygen species [186] 
and consequently lipid peroxidation [187], caspase activation, and eventually 
programmed cell death (apoptosis) [188]. Taken together, these results indicate that 
hematuria can act as a diagnostic factor for the presence of renal ailments and can, at 





frequent at the early stages of the disease, while microhematuria is associated with 
worse renal outcomes and a higher incidence of patients with end-stage renal disease 
(ESRD).  
All of these results suggest that detecting microscopic hematuria is critical to 
predicting and recognizing patients at high risk of developing CKD, which enables 
healthcare professionals to take proactive measures to stop the initial stages of CKD 
from progressing to ESRD [189, 190]. In the following section, the discussion of 
different methods to assess hematuria has been done. This discussion will be followed 
by the presentation of a new approach for investigating the dielectric properties of 
urine samples with blood cells as a new, real-time, noninvasive method that can be of 
great use in the clinical setting. 
4.1.1 Methods Used for Testing Hematuria 
Dipstick urinalysis is an old standard for testing the presence of blood cells. A blood 
sample with hematuria generates a greenish-blue color, which results from the 
oxidation of a chromogenic substrate, tetramethylbenzidine, by the peroxidase activity 
of hemoglobin [187]. Different companies use different chromogenic substrates for 
this purpose. A dipstick is believed to detect as low as 2-5 RBCs/HPF, which is 
equivalent to 10 RBCs per µl. However, this method has some pitfalls, such as false 
positive results in certain cases like hemoglobinuria and myoglobinuria, which have 
different etiologies from hematuria, in which the urine does not contain any blood cells 
[191, 192]. The positive results in these conditions do not result from the presence of 
RBCs but rather from the pigments released from lysed blood cells or from muscle 
damage, respectively. Dipsticks can also give false positive results when bacterial 





of urine with oxidizing agents used in cleaning solutions or with menstrual blood in 
women. Additionally, the urine of patients taking vitamin C supplements might 
generate false negative results [192]. The presence of RBCs in urine can also be 
confirmed by a microscopic examination of the sediment of spun urine under an HPF, 
what is known as microscopic urinalysis and the count is usually described as 
RBCs/HPF [192]. This approach is the conventional method but concerns regarding 
RBC loss as a result of cells sticking to the walls of the tube during centrifugation or 
during decanting of the supernatant remain. To avoid these artifacts, some researchers 
favor counting the cells in uncentrifuged urine using a Coulter counter [193]. A 
cytological semiquantitative method was shown to be more accurate than both the 
conventional and dipstick methods.  
In this method, the sediment of urine is spread over many slides, fixed and stained, and 
then, cells are counted under a microscope. This method was able to detect blood cells 
at concentrations of less than 50 RBCs per ml, while the minimum concentration 
detected by the conventional method was 500 RBCs per ml. Surprisingly, dipsticks 
from different companies could detect minimum concentrations ranging from 2×104 
to 1×106 RBCs per ml, which is much larger than the number claimed by companies 
[194]. Dipsticks are attractive for the initial screening of urine samples since they can 
detect several abnormalities in urine, in addition to being inexpensive, fast and easy to 
use. One study showed that the use of a dipstick is very reliable since further 
microscopic analysis of the same tested samples did not change the treatment decisions 
that were based on the dipstick results [195]. Regarding the detection of hematuria, 





and microscopic analysis when used under unstandardized conditions 
(hyperhydration) [196]. 
Usually, a positive result for a dipstick is followed by a microscopic examination to 
confirm hematuria, which consumes a considerable amount of time. A false negative 
result is even worse and can result in misdiagnosis, which can be dangerous to patient 
health. More developed and sophisticated methods for urine analysis involve the use 
of automated analyzers. Different analyzers can have different analytical principles 
and might require different sample preparations. Some of these analyzers are based on 
flow cytometry, where fresh urine samples are used to determine the particle size and 
complexity by light scattering and additional sample staining can give more 
information about DNA [197]. Other analyzers are based on image analysis in which 
urine sediment is analyzed by obtaining particle images using integrated cameras, 
which are analyzed using predefined libraries [198, 199].  
Although these automated methods can save time in high-volume labs, they still 
require the presence of well-trained professional technicians who need to accept or 
reject the results or reclassify them, especially for image-based methods. Moreover, 
one cannot ignore the costly charges of instrument maintenance [199], which has 
always been a motivation factor in finding newer, less expensive methods that allow 
accurate and instant results, thus saving time in addition to minimizing maintenance 
charges. This study investigates the use of the electrical properties of urine to detect 
both RBCs and white blood cells (WBCs) in urine, which can be cost effective and 





4.2 The Current Approach 
 
Figure 4.1: Illustration of cell with a negatively charged glycocalyx (a) blood cell with 
a negatively charged glycocalyx coated by positively charged ions in urine. (b) the 
random distribution of blood cells in a suspending medium (urine). L is the length of 
the total capacitor; d is the distance between the two electrodes of the capacitor. (c) 
Diagram showing how the surface-bound charged ions diffuse under the effect of an 
applied electric field, leading to cell polarization. (d) An alternative two-zone parallel 
capacitance model of the cell distribution inside a capacitive structure. LUrine and LBlood 
cell are the lengths of the capacitor zones occupied by the medium (urine) and blood 
cells, respectively. 
Suspensions of biological cells are known to interact with an applied electric field by 
experiencing different levels of polarization; therefore, such suspensions can be treated 
as a dielectric material that affects the capacitance, which can be measured by a 
capacitor. The nonhomogeneous nature of cells arises from their complex 
composition; cells comprise proteins, carbohydrates, nucleic acids and lipids in 





polarized when subjected to an electric field. The strength of the polarization depends 
on the composition and how cells interact with the suspending medium [200]. A cell 
suspension exhibits a unique response to an electric field since its response is 
frequency dependent with at least three incremental losses or dispersions, known as α, 
β and γ dispersions [201]. 
Figure 4.1(b) illustrates how cells suspended in urine are randomly distributed inside 
a capacitor. When a cell is placed under the effect of an applied electric field, it 
becomes polarized, and one type of polarization results from the diffusion of the 
charged ions present at the cell surface, resulting in a large dipole (see Figure 4.1(c)). 
For simplicity and modeling, the cell distribution inside a capacitive structure is 
assumed to consist of two separate zones, and a parallel model is shown in Figure 
4.1(d). The volumes of the cell and medium zones are the same as their respective 
actual volumes in the suspension in both the parallel and series representations. 
4.3 Materials and Methods 
4.3.1 Collection of Urine Samples 
A fresh, early morning urine (EMU) sample (30-50 ml) was collected in a sterile urine 
container with no additional preservatives. 
4.3.2 Separation of RBCs and WBCs 
Whole blood (5-10 ml) collected in an EDTA vacutainer was centrifuged at 377xg for 
10 minutes at 4°C. Blood separates into three components: plasma (top), buffy coat 
(middle) and RBCs (bottom). The top plasma layer was carefully removed and 
discarded without disturbing the buffy coat. The buffy coat containing the WBCs was 





the contaminating RBCs in the buffy coat fraction, 10 ml of RBC lysis buffer (2 mM 
Tris HCl, 5 mM MgCl2, pH 7.5) was added to the buffy coat and mixed so that the 
RBCs were lysed while maintaining the WBCs intact. The WBCs were pelleted at 
672xg for 20 minutes at 4°C. The RBC lysis step was carried out twice to completely 
remove the RBCs. The WBCs were then suspended in 10 ml of Dulbecco’s Modified 
Eagles Medium (DMEM, HyClone) and counted using a hemocytometer to prepare 
the required dilutions. Meanwhile, the bottom RBC-containing layer was transferred 
to a fresh 50-ml falcon tube and washed twice with 5 ml of PBS, suspended in 10 ml 
of DMEM, and counted using a hemocytometer to prepare the required dilutions. 
4.3.3 Preparation of Dilutions 
The purified RBC and WBC suspensions were separately prepared using fresh urine. 
The dilutions initially prepared were 106, 104, 102, and 101 cells/ml in DMEM for 
RBCs and WBCs. Immediately before being loaded into the coaxial adaptor for 
electrical characterization, the cell suspension in DMEM was centrifuged at 1,050xg 
for one minute. The supernatant was carefully separated and resuspended in 1 ml of 
fresh urine. The sample was then used for electrical characterization. After electrical 
characterization, the same sample was collected in a micro centrifuge tube and 
centrifuged at 1,050xg for one minute. The supernatant was carefully separated and 
loaded into coaxial cable for electrical characterization. 
4.3.4 Electrical Measurements 
The electric measurements were conducted by loading 500 µl of each cell suspension 
in urine or urine alone into an open-ended coaxial cable connected to Gamry 3000 





over a range of frequencies from 100 MHz to 100 kHz. The instrument can record 
different types of electrical measurements, such as capacitance-voltage (CV) profiles. 
Due to the frequency and current ranges used, the device can measure capacitance with 
a high precision (up to zeptofarad). Figure 4.2 illustrates the experimental setup used 
and the electrical modeling and electric circuit for blood cells in urine. 
 
 
Figure 4.2: Illustration of the electrical modelling of blood cells suspended in urine. 
(a) Panel (i) demonstrates the random distribution of blood cells before the application 
of a DC bias, panel (ii) shows the distribution of blood cells after the application of a 
DC bias, and panel (iii) depicts how cells act as dipoles when exposed to an electrical 
field. (b) Depiction of the corresponding equivalent circuit model, where CS is the 
suspension (blood cells and urine) capacitance, CU is the urine capacitance, and Cb is 
the capacitance of the blood cells. 
4.4 Results 
Figure 4.3 (a) displays capacitance curves measured over a range of frequencies (1-
105 Hz) for urine samples spiked with increasing concentrations of RBCs (102 to 106 
cells/ml). The electrical measurements were made by loading the cell suspensions in 





electrical potential. In general, the capacitance curves displayed a smooth pattern, with 
the highest values occurring at low frequencies. A gradual decrease in capacitance 
occurred as the frequency applied to the capacitor increased.  
The capacitance-frequency (CF) curve for urine alone (sample P0 in Figure 4.3 (a)), 
which acted as a control sample, was below the rest of the curves, indicating a low 
capacitance potential of urine. Unexpectedly, the capacitance values for urine/blood 
suspensions were inversely proportional to the RBC concentration; the sample with 
the highest number of cells (106) generated the lowest curve, while the curves shifted 
to higher values with decreasing concentration of blood cells (Figure 4.3 (a)). Figure 
4.3 (b) displays curves of suspensions where the urine samples were spiked with 
increasing concentrations of WBCs. Similar to the pattern observed with RBCs, urine 
samples spiked with the highest concentrations of WBCs resulted in the lowest 
capacitance; thus, the capacitance was inversely proportional to the concentration of 






Figure 4.3: Dielectric properties of urine and cell suspensions measured over a range 
of frequencies. (a) Capacitance versus frequency profile for increasing concentrations 
of RBCs) and (b) WBCs in urine. The curves labeled P0, P2, P3, P4, P5, and P6 
correspond to concentrations of 0, 102, 103, 104, 105 and 106 cells/ml, respectively. (c) 
Time-dependent changes in the capacitance of the fresh urine sample devoid of cells 
used for RBC and (d) WBC suspensions. The changes in capacitance versus time were 
measured at 1 Hz. UP0, UP2, UP3, UP, UP5, and UP6 are urine samples measured 
electrically at the times shown in the figures, which were exactly the times at which 







Figure 4.4: Capacitance-voltage (CV) profiles of urine samples containing increasing 
concentrations of RBCs and WBCs. (a) CV profile of the control urine sample and 
urine samples spiked with increasing concentrations of red blood cells (RBCs). 
Samples RBCP0, RBCP2, RBCP3, RBCP4, RBC5 and RBC6 had cell concentrations 
of 0, 102, 103, 104, 105 and 106 cells/ml, respectively. (b) CV profile of urine only and 
urine samples with increasing concentrations of white blood cells (WBCs). Samples 
WBCP0, WBCP2, WBCP3, WBCP4, WBC5 and WBC6 had cell concentrations of 0, 
102, 103, 104,105 and 106 cells/ml, respectively. (c) CV values of each suspension 
recalculated by de-embedding the capacitance of urine “alone” obtained by 
centrifuging the supernatant and measuring its capacitance after each suspension 
capacitance measurement from the capacitance of the RBC suspension. (d) Similarly, 
recalculated WBC suspension CV values as in (c) after de-embedding the values of 
urine alone. 
Figures 4.3 (c) and (d) display the variations in the capacitance of the sample (fresh 





repeatedly measuring the urine capacitance at the time points at which each suspension 
of RBCs or WBCs was made. In general, the capacitance for urine samples in both sets 
of experiments displayed a stable increase with time (measured over 35 minutes), as 
shown in Figures 4.3 (c) and (d), revealing that urine (the control sample) alone 
undergoes dynamic changes that can affect its electrical parameters, leading to a 
gradual increase in capacitance with time.  
Figure 4.4 (a) displays capacitance curves measured over a range of voltages (-0.5 to 
+0.5 V) for urine samples containing increasing concentrations of RBCs. As with the 
CF profiles, the CV curve for the urine only sample (as a control) was below all the 
other curves, showing less capacitance potential for urine, while the capacitance values 
for the rest of the samples were inversely proportional to the concentration of cells in 
the samples. 
A similar pattern was observed for urine samples containing increasing concentrations 
of WBCs (Figure 4.4 (b)), as shown in Figure 4.3 (b). To determine if the inverse 
relationship observed with increasing cell concentration was due to the instability 
observed with urine alone, the CV values observed for the cell suspensions were 
corrected for those of urine alone. Figures 4.4 (c) and (d) show corrected versions of 
the CV curves displayed in Figures 4.4 (a) and (b), respectively, after de-embedding 
the capacitance of the control urine sample from the suspension capacitance. Briefly, 
each cell suspension was reconstituted just before the measurement was performed. 
After the measurement, the sample was centrifuged, and the supernatant representing 
the fresh urine status at this time was subjected to electrical measurements.  
The capacitance values of each supernatant urine sample were deducted from those of 





were corrected for any artifacts that might have arisen from any possible changes 
occurring in the urine over time. The curves plotted after the correction step revealed 
a more logical pattern, where spiking more cells into urine led to a stepwise increase 
in the capacitance potential of urine. These data also revealed that 100 cells/ml could 
easily be distinguished from urine alone for both cell types across most of the range of 
frequencies tested (Figures 4.4 (c) and (d)). 
 
Figure 4.5: Dipstick analysis of fresh urine containing one million cells/ml. The image 
on the left shows the urine strip dipped in fresh urine without any cells, while the image 





Next, the limit of detection of this electrical technique has been compared with that of 
the current method of choice for hematuria, the “urine dipstick” method. To this end, 
the red blood cell suspension in urine with the highest concentration of cells, 106 
RBCs/ml, was tested by a dipstick. Surprisingly, the dipstick revealed a normal urine 
status with no indication of the presence of RBCs, although dipsticks are claimed to 
be sensitive, with the ability to detect from 2×104 to 1×106 cells/ml, as shown in Figure 
4.5. In contrast, proposed method could detect RBC concentrations with nearly 
10,000-fold fewer cells/ml (as low as 100 cells/ml). 
Next, the capacitance values in Figures 4.4 (c) and (d) were used to extract the 
dielectric constants for cell suspensions over a range of voltages, and these values were 
normalized by calculating the ratio between the dielectric constant of each suspension 
and the dielectric constant of the urine control sample measured at the very beginning 
of the measurement. The normalized values of the dielectric constants were plotted for 
both types of cell suspensions, as shown in Figures 4.6 (a) and (b). Calibration curves 
were generated by plotting the ratios calculated at -0.25 V (the middle of the negative 
voltage range) for each concentration of cells, as shown in Figure 4.6 (c). Figure 4.6(c) 
presents the change in the dielectric constant of the suspension versus the 
concentration of both cell types.  
Figure 4.6 (d) was used to examine quantity of cells in urine by extracting the 
corresponding dielectric constant from the measured suspension capacitance. For a 
high cell concentration, Figure 4.6 (d) reveals the possibility of identifying the cell 
type if the value of the extracted normalized constant is greater than 1.75 (as indicated 
by the vertical line). For concentrations with less than 104 cells per ml, both RBCs and 





curves for cell identification below this range difficult. Nevertheless, as can be 
concluded from the data displayed in Figures. 4.4 (c) and (d), the recorded capacitance 
values for the two types of cells at the same concentration were different. Hence, the 
capacitance per cell can be used to differentiate the cell types. 
 
Figure 4.6: Extraction of the dielectric constants and cell counts from the electrical 
measurements.(a) Ratios of the dielectric constant of each cell suspension to the 
dielectric constant of the urine only sample plotted over a range of voltages (-0.5 to 
+0.5 V) for red blood cells (RBCs). Samples RBCP0, RBCP2, RBCP3, RBCP4, RPC5 
and RPC6 had 0, 102, 103, 104, 105 and 106 cells/ml, respectively. (b) Same calculations 
for the white blood cell (WBC) urine suspensions. Samples WBCP0, WBCP2, 
WBCP3, WBCP4, WBC5 and WBC6 contained 0, 102, 103, 104,105 and 106 cells/ml, 
respectively. (c) Ratios calculated at a voltage of -0.25 V plotted against the cell 
concentration for RBCs and WBCs. (d) Replotting of figure (c) with reversed axes to 






In this study, the dielectric properties of urine are characterized which presented the 
ability to detect, quantitate, and distinguish between two different types of blood cells 
present in urine based on their electrical parameters. The results show that using 
proposed approach, it can detect a minimum of 102 blood cells/ml of urine. Study of 
the dielectric properties of urine has been gaining more interest in the last few years. 
Such studies can pave the way for fast and noninvasive methods that can be very 
practical for clinical utility. For example, in one study, electrical measurements were 
recorded for urine samples of normal patients and patients with CKD with proteinuria 
at frequencies from 0.2-50 GHz and at three different temperatures [202]. Below 7 
GHz, the urine of patients with CKD had higher dielectric properties than that of 
normal subjects, with the differences becoming more significant at higher 
temperatures of 30°C and 37°C. This trend was reversed above 7 GHz. Similarly, a 
positive correlation between proteinuria level and dielectric properties was observed 
below 7 GHz, while a negative correlation was observed above this point. The lower 
relaxation frequency observed in samples with proteinuria was explained by a decrease 
in bulk water, leading to slower relaxation times [202]. Similar results were also shown 
when the urine of patients with diabetes and CKD was compared to that of normal 
subjects, but the differences were more significant between normal patients and 
patients with CKD [203]. Other studies have investigated the effect of glycosuria on 
the dielectric properties of urine and observed an increase in the dielectric constant 
with increasing glucose in urea [204–207]. All these studies demonstrate the 
biomaterial dependence of urine dielectric properties. Not much research has been 
done related to the dielectric properties of urea from patients exhibiting hematuria or 





discussed, the presence of RBCs is a very important prognostic factor for CKD, while 
WBCs can indicate the presence of infection. 
In the present study, no real samples have been used from patients; rather, to establish 
the proof-of-principle, the effects of RBCs and WBCs on urine dielectric properties 
has been investigated. This investigation was achieved by spiking fresh urine with 
increasing concentrations of RBCs and WBCs. Surprisingly, the dielectric properties 
were not as expected because the urine CF curves, and the cell concentration exhibited 
an inverse correlation (Figures 4.3 (a) and (b)). This unexpected result raised the 
question of the stability of urine, which possibly affected its electrical properties, thus 
leading to this artifact. To test this possibility, the dielectric property of the fresh urine 
sample was measured after each suspension reading by spinning the suspension and 
removing the cells. Interestingly, it is observed a stepwise increase in the CF profile 
of urine alone with time (Figures 4.3(c) and (d)). This finding highlights the issue of 
urine stability over time. The observed dynamic changes in urine are possibly ascribed 
to some chemical reactions that can occur, altering the chemical composition of urine 
and consequently altering the intrinsic capacitance of urine over time. As a biological 
fluid, urine comprises of sodium chloride, phosphate, potassium, urea and trace levels 
of calcium, sulfate, and magnesium [208]. Fresh urine pH ranges from 5.6 to 6.8 [209]. 
Urea is one of the components degraded by the action of the urease enzyme found in 
some infectious microorganisms, breaking it into ammonia and carbon dioxide, thus 
raising the pH of urine to 9 [210]. One study showed that changes in the pH and 
ammonia concentration of fresh urine reach a steady state after 60 to 72 hours [207]. 
Moreover, this change is accelerated at higher temperatures (such as, 25°C and 30°C) 





observed after one hour, but some parameters changed after a 24-hour period of 
refrigeration [212]. 
In this study, it has been showed that dynamic changes occur in urine in short periods 
of time (30 minutes) and that these changes can be electrically detected, but not by 
conventional methods. The electrode polarization (electric double layer) is augmented 
by the presence of free mobile ions in a suspension, and this phenomenon can lead to 
an increase in the capacitance of a suspension [213]. It has been suggested that the 
dynamic changes of urine with the generation of free ammonia ions and carbonate ions 
may lead to the increase in capacitance observed over time. Another explanation can 
be an increase in the density of dipoles as a result of dynamic chemical changes. In 
fact, this phenomenon was proposed to explain the high dielectric constant observed 
for the blood of people with diabetes [214]. Furthermore, the results revealed that the 
CV profiles of the cell suspensions in urine (Figures 4.4 (a) and (b)) had patterns 
similar to those observed in the CF profiles. The capacitance of cell suspensions using 
the following formula can be described as:   
C Suspension = C Urine + C Cells (RBCs or WBCs)                         (4.1) 
This formula shows that de-embedding the CV values of each urine control sample 
from the CV values of the urine suspensions made at the corresponding times should 
yield the actual CV value of cells (Figures 4.4 (c) and (d)). As observed, after the de-
embedding process, the CV curves became positively correlated with the cell 
concentrations in urine. The ratio of the dielectric constant of each cell concentration 
(RBCs/WBCs) to the dielectric constant of fresh urine was calculated for each value 
over the range of voltages, as shown in Figures 4.6 (a) and (b). The ratios calculated 





concentration curves (Figure 4.6(c)). These curves were used to extract the 
concentration of cells in urine. This technique can detect cell numbers as low as 100 
cells per ml, which is even more sensitive than any available urine dipstick test since 
these tests can detect a minimum of 2×104 to 1×106 RBCs per ml.  
Similarly, WBCs could also be detected at low concentrations, 100 cells/ml. This study 
emphasizes on the ability to detect the dynamic changes in urine alone can also be 
important, especially if these changes result from bacterial activity that can result in 
even a higher rate of change in infected urine. This approach can be faster than 
conventional microbiological techniques that require lengthy microbial culture and 
proper interpretations. In proposed case, a high ratio of the rate of change of a suspect 
sample to the rate of a normal sample could act as an indication of infection since the 
urine sample was not handled in a sterile manner once it was used for the dilutions. 
Further investigation of this novel method and its validation can provide easier and 
more efficient modalities for urine examination, especially in high-volume labs where 
time is critical. The proposed method has been cross-checked using repeated electrical 
measurements against multiple cells stocks prepared at different times, i.e., all within 
the employed frequency range and over the same applied bias voltage. As detailed, the 
accuracy of these measurements using the outlined methodology is comparable with 





Chapter 5: Electrical Characterization of Calcium Oxalate in Urine 
Urolithiasis is a very common problem worldwide, affecting adults, kids and even 
animals. Calcium oxalate is the major constituent of urinary tract stones in individuals, 
primarily due to the consumption of high oxalate foods. The occurrence of urinary 
oxalate arises due to endogenous synthesis, especially in the upper urinary tract. In a 
normal, healthy individual, the excretion of oxalate ranges from 10 to 45 mg/day, 
depending on the age and gender, but the risk of stone formation starts at 25 mg/day 
depending on the health history of the individual. This study demonstrates a label-free, 
accurate and sensitive method for detecting the presence of kidney stones in urine by 
measuring changes in the dielectric properties of urine with increasing concentration 
of calcium oxalate hydrate (CaOx.H2O) powder. The current method can detect 
dynamic changes in the electrical properties of urine over time in samples containing 
CaOx.H2O at a concentration as low as 10 µg/ml of urine, making this method suitable 
for detecting changes that cannot be recognized by conventional methods. The ability 
to detect very small amounts of stones makes this method an attractive tool for 
detecting and quantifying kidney stones. 
5.1 Overview 
Nephrolithiasis is a usual malady, with a predictable recurrence rate of five years in up 
to 50% of cases [215]. Due to the continuous change in dietary proclivity and lifestyle, 
the ubiquity of calculi has steadily grown over the past decades [216, 217]. The risk 
factors leading to urolithiasis are polydipsia [218–220], corpulence [221], 
hypertension [216, 220, 222] and insulin resistance syndrome [223], which may result 





concentrated with respect to certain minerals, resulting in crystallization in the 
kidneys; these crystals further grow and are retained within the kidneys ducts [228]. 
Many published reports have shown that all kinds of kidney calculi contain several 
trace elements, such as Ca, Mg, Mn, Cu, Fe, K, Zn, Cd, B, and Se [229–231]. However, 
calcium stones are the most prevalent, especially calcium oxide (CaOx) and calcium 
phosphate (CaP) crystals, which exist alone or as fusions. Hyperoxaluria is a metabolic 
disorder that might lead to end-stage renal failure and is defined as the excessive 
urinary excretion of oxalate anions [232]. CaOx is a calcium salt of dicarboxylic acid 
and oxalic acid that occurs as a dihydrate or monohydrate, i.e., whewellite (COM) and 
weddellite (COD). Among all calcium stones, COM stones are the most common ones 
that occur globally [233]. 
Precise analysis of renal calculi is a prerequisite for metaphylaxis. Currently, available 
analysis techniques include spectroscopy, thermogravimetry (TG), polarization 
microscopy, chemical analysis, scanning electron microscopy (SEM) and powder X-
ray diffraction [234, 235]. Moreover, spectroscopy includes various effective analysis 
techniques, such as infrared spectroscopy (IR), energy dispersion X-ray analysis 
(EDX), laser-induced breakdown spectroscopy (LIBS), laser ablation-inductively 
coupled plasma-mass spectrometry (LA-ICP-MS) and X-ray absorption spectroscopy 
(XAS) [8, 236–239]. However, no solitary technique can provide comprehensive 
information on the chemical composition of kidney stones, indicating that 
combinations of these methods are needed for analysis [240]. 
Recently, various studies have been carried out on calculi behavior, detection, and 
quantification. The detection of kidney stones can be performed on the basis of 





dielectric constant, polarization, and capacitance [15, 16]. Urinary pH affects the 
formation of stones; an alkaline pH supports the growth of Ca and P stones, whereas 
an acidic pH favors uric acid or cystine calculi [241]. 
In this proposed study, electrical characterization has been done along with urine strip 
analysis of urine samples with calcium oxalate hydrate powder (which is one of the 
main components of calcium oxalate kidney stones). 
5.2 Results and Discussions 
Calcium oxalate hydrate (CaOx.H2O) (Sigma-Aldrich, United Kingdom) powder, 
which is a main component of kidney calculi, has been used for the experiments. A 
fresh urine sample was collected and centrifuged to prepare suspensions in urine. The 
same urine sample was used for both electrical characterization and urine strip analysis 
and was used as one of the reference samples for the study. The rest of the urine sample 
was centrifuged at 3x103 rpm for five minutes and used as the diluent for suspending 
the CaOx.H2O powder. The quantity of CaOx.H2O powder varied from 10 mg to 1 
mg, 100 µg and 10 µg per ml of urine sample. A fresh normal urine sample and pure 
oxalate powders were also used for the analysis. 
5.2.1 Urinalysis 
Urinalysis test strips (SD Uro-Color 10, Republic of Korea) has been used for the 
finding of key biomarkers (blood, bilirubin, urobilinogen, ketone, protein, nitrite, 
glucose, pH, specific gravity and leucocytes) in urine. The chemical pads react with 
urine and generates a color that could be analyzed by comparing to the color chart to 
determine the level of each parameter [241]. A complimentary area is also provided at 





The urine samples were collected, processed and stored in clean, dry containers. The 
tests were conducted one by one. A reagent strip was removed from the container and 
the cap was immediately replaced to minimize exposure of the remaining test strips to 
light and air. The chemical pads were completely immersed in the urine samples and 
instantly removed to prevent dissolution of the pads. The excess urine has been 
removed to prevent any cross-contamination of chemicals placed on adjacent reagent 
pads. The color change of pads has been compared to the corresponding color chart 
and the results were recorded for each panel. 
Urinalysis was conducted by treating urine strips with urine samples. Figure 5.1 shows 
the urine strips treated with fresh urine and centrifuged urine containing different 
dilutions of CaOx.H2O. Fresh and centrifuged urine were used as references. 
Comparison of the reference urine strips with those treated with urine containing 
different dilutions of CaOx.H2O showed a change in the pH value, which is a 
prominent parameter used for quick detection of pathological changes in urine [242]. 
The normal urine pH is approximately 6.0 but can range from 4.5 to 8.0 [243]. The 
reference samples exhibited a pH of 6.0. The CaOx.H2O urine suspensions at dilutions 
of 10 mg/ml and 1 mg/ml exhibited a pH of 6.0. The pH of urine with dilutions of 100 
µg/ml and 10 µg/ml calcium oxalate decreased to 5.5.  
The color pads on the reagent strips for the other parameters did not show considerable 
color changes compared to the reference sample strips. The other parameters used to 
indicate changes were as follows: glucose - 100, leukocytes – 75, bilirubin – 1.0 to 0.5, 
protein – 1 and specific gravity – 1.030. The urinalysis results are depicted in Table 
5.1, which indicates that the pH and bilirubin have slight variations when the quantity 








































































































































































Table 5.1: Urinalysis of Calcium Oxalate Hydrate Powder in Centrifuged Urine 
 
Calcium oxalate hydrate powder (CaOx.xH2O) in 
centrifuged urine 
10 mg/ml 1 mg/ml 100 g/ml 10 g/ml 
pH 6.0 6.0 5.5 5.5 
Glucose 100 100 100 100 
Blood Neutral Neutral Neutral Neutral 
Bilirubin 1 0.5 0.5 0.5 
Urobilinogen 4 4 4 4 
Ketone Neutral Neutral Neutral Neutral 
Protein 1 1 1 1 
Nitrite Neutral Neutral Neutral Neutral 
Specific Gravity 1.030 1.030 1.030 1.030 
Leucocytes 75 75 75 75 
Calcium oxalate hydrate was artificially introduced into fresh, centrifuged urine 
samples at a range of dilutions based on mass, i.e., 10 mg/ml, 1 mg/ml, 100 µg/ml and 
10 µg/ml of urine. A normal, healthy individual voids 1000-2000 ml of urine per day 
[242]. Normal levels of urine oxalate excretion are less than 45 mg/day (<0.50 
mmol/day) [244]. Subjective to the age, gender, health history and numerous other 
parameters, the risk of calculi formation is higher even at small amount of 25 mg/day, 
which is considered to be a normal quantity [245]. Thus, 10 µg of CaOx.H2O per ml 
of urine was selected as the lowest dilution for the test. 
Urine strips are the preliminary and central diagnostic method for yielding quick and 
reliable information on pathological changes in urine [242]. This data shows that the 
presence of calcium oxalate crystals in urine results in a change in pH. The pH of the 
fresh, as well as centrifuged, urine samples remained at 6.0, which is the normal urine 
pH [243]. The color pads of the urine containing CaOx.H2O dilutions showed slight 
changes in color. The pH remained at 6.0 for the 10 mg/ml and 1 mg/ml samples but 





pH can be supported by the occurrence of calculi composed of calcium, oxalate, 
proteins, citrate and other macro-molecules; in proposed case, the decrease is due to 
the presence of oxalate powder [246]. The potential danger of calculi formation is 
associated with the formation of crystals present in urine. Studies have shown that 
COM crystal formation is associated with the occurrence of high amounts of oxalate 
[247]. Conte et al. showed that calcium oxalate hydrate present in the renal stones 
exhibits a relationship with the urinary parameters [248]. 
Other parameters that exhibit deviations from the normal values are glucose, 
leukocytes and bilirubin. The glucose component on the urine strip indicated a value 
of 100 due to the trace amounts of glucose normally excreted in urine [248]. The 
presence of leukocytes is indicated by the value of 75 in the test strip, which 
corresponds to a negligible amount and might not indicate an infection of the urinary 
tract [249]. Bilirubin conjugates with glucuronic or sulfuric acid and appears in urine. 
The presence of conjugated bilirubin in human urine (indicated by the values of 1.0 to 
0.5 in the urine strip) is commonly associated with liver disorders such as hepatitis, 
cirrhosis, gallbladder disease and various hepatocellular cancers [250]. Urobilinogen 
is formed by bacterial action on conjugated bilirubin and its appearance in urine is 
caused mostly by hemolysis or hepatocellular dysfunction. The protein component in 
the test strip exhibits a color range corresponding to a value of 1 and protein enters 
urine due to either altered renal functions, such as permeability, or tubular damage 
[251]. Adults have a specific gravity of 1.005 to 1.030 [252]. 
5.2.2 Electrical Characterization 
The sample dilutions prepared using the centrifuged urine were used for electrical 





reference urine samples as well as the urine suspensions inside the coaxial cable of a 
Gamry Reference 3000 (Gamry/USA) instrument and measuring the electrical 
parameters of the samples. The GR-3000 is a high-performance, high-current, USB 
controlled potentiostat with various current ranges from 3 A to 300 pA and up to a 32 
A compliance voltage. This instrument takes measurements over a frequency span 
from 10 μHz to 1 MHz. The capacitance values of the samples were measured over a 
voltage span from -0.4 V to 0.4 V at a frequency of 10 Hz, values suitable for 
polarizing the suspended particles without altering the traits of the components inside 
the sample. At this frequency, the SNR is improved, and the frequency impedance 
spectra exhibit constant phase angle (CPA) and amplitude. The experimental setup has 
been depicted in Figure 5.2. 
 






Figure 5.3:Capacitance-voltage (CV) measurements of calcium oxalate powder 
suspensions in urine. 
The capacitance-voltage (CV) profiles for CaOx.H2O suspended in urine with 
increasing concentrations from 10μg/ml to 10mg/ml are depicted in Figure 5.3 (a). The 
capacitance of the samples was measured over a voltage span from -0.4V to 0.4V at a 
frequency of 10 Hz. The applied voltage range and frequency are suitable for 
polarizing the suspended particles; beyond this range, the traits of the components 
inside the sample may be altered [253]. Moreover, a low frequency of 10 Hz is 
desirable to improve the signal-to-noise ratio (SNR), and at this frequency, impedance 
spectra exhibit CPA and amplitude [254, 255]. As revealed from Figure 5.3 (a), the 
capacitance for CaOx.H2O suspensions were inversely proportional to the CaOx.H2O 
concentration; i.e., the sample with the highest amount of calcium oxalate powder 
generated the lowest curve, while the curves shifted to higher values with decreasing 





parallel; however, for the positive DC bias, the curves showed increasing trends. This 
phenomenon may be due to the change in the physical and dielectric properties of the 
calcium oxalate when the polarity of the applied voltage changes [256]. The average 
capacitance values over the negative applied voltage are 26.72μF, 18.8μF, 13.88μF 
and 11.40μF for the samples with oxalate powder concentrations of 10μg, 100μg, 1mg 
and 10mg per ml of urine, respectively. 
The curves of the suspensions were expected to follow a direct relationship between 
the capacitance and CaOx.H2O concentration in samples, i.e., for a higher calcium 
oxalate powder concentration, the capacitance value should be higher. Nevertheless, a 
contrasting trend was observed. This phenomenon can be attributed to the dynamic 
nature of urine, which varies over time. To verify the time dependence of urine, control 
samples from the suspended samples has been prepared, which acted as references for 
further measurements. 
 
Figure 5.4:Capacitance-voltage (CV) profiles of control urine after centrifugation of 





After the measurements, to concoct control samples, the suspended samples were 
centrifuged and the supernatants were subjected to electrical measurements. The 
corresponding CV measurements of the control samples are depicted in Figure 5.4. 
Comparing both figures, Figure 5.3 and Figure 5.4, a homologous pattern of capacitive 
curves was observed. This comparison reveals that the control samples have higher 
values than the corresponding suspended samples. The extraction of the supernatant 
from its corresponding suspended samples excludes the effect of the sediment [257], 
leading to aberrations in the capacitive values for the control samples. Except for the 
1 mg control sample, all the samples have an increasing slope for the positive applied 
voltage; however, for the negative DC bias, all curves are analogous. The average 
capacitance values over the negative DC bias are 28.76μF, 23.2μF, 15.8μF, and 
11.48μF for the samples with oxalate powder concentrations of 10μg, 100μg, 1mg and 
10mg per ml of urine, respectively. 
The time-dependent dynamic nature of urine is shown in Figure 5.5. The chronological 
measurements were taken with an approximately 20-minute gap up to one hour to 
measure the control urine capacitance. As the overall urine properties and parameters 
critically depend on the time window, performing the study within the time period of 
90 minutes is recommended [215, 258]. This curve shows a linear increase in the 
capacitance from 11.65μF to 28.7μF within an hour. This result indicated that the 
control sample undergoes some dynamic changes over time. The changes are mostly 
chemical, which can alter the electrical parameters, leading to a gradual increase in 
capacitance with time. A fitted curve was generated using a linear regression model 
with the extracted parameters, as depicted in the inset of Figure 5.5. The fitted and 






Figure 5.5: Time-dependent changes in urine sample capacitance, depicting 
measured data and the fitted curve. An inset table of the curve fitting parameters is 
also shown. 
 
Figure 5.6: Capacitance-voltage (CV) profiles of oxalate powder suspensions after 





The estimation model parameters show very little deviation from the actual empirical 
values of the data. The adjusted R-square value is 0.9812, approaching one, which 
indicates that the model well predicts the values in the target field. The rate of change 
of urine over time can be expressed as the slope of the fitted curve, which is 
0.295μF/min. 
 
Figure 5.7: Capacitance-mass (CM) profile, with logarithmically increasing powder 
concentrations of 10 μg, 100 μg, 1 mg and 10 mg versus capacitance. 
The rate of change of urine was used to de-embed the dynamic effect of urine from the 
suspended sample results. By performing this step, the capacitance values were 
corrected for any possible changes occurring over the experimental time window. 
After excluding the dynamic effect of the urine from the samples with various 
concentrations of suspended oxalate powder, the effective capacitance over the 





capacitance values of each supernatant urine sample were deducted from those of the 
corresponding urine suspension of CaOx.H2O powder. A reverse trend of normalized 
capacitance values can now be observed over the negative applied voltage compared 
to Figure 5.4, i.e., 10mg > 1mg > 100μg > 10 μg within the range of 4-12μF. Even the 
average magnitude is reduced, to 4.623μF, 5.164μF, 6.415μF and 11.3μF for the 
CaOx.H2O concentrations of 10μg, 100μg, 1mg and 10mg per ml, respectively. 
The capacitance-mass (CM) logarithmic profile for the saturation growth rate model 
of mass with respect to capacitance is depicted in Figure 5.7. With increasing 
CaOx.H2O mass concentration from 10 μg to 100 μg, 1 mg and 10 mg, the capacitance 
ranges from 0-12 μF. The curve shows a gradual increase in the mass. The mass 
initially shows a steep increase and later tends to stabilize with increasing capacitance. 
Other studies also showed the change in the mass of stones. For instance, Ananth et al. 
investigated an in vitro method that manifests the change in the crystal size of calcium 





Chapter 6: Conclusion and Future Scope 
6.1 Conclusion 
An innovative and easy technique for the detection of cells/stones in urine is proposed 
in this study. The method involves label-free identification and quantification of cells 
and calcium oxalate in urine based on electrical parameters without any preprocessing 
steps. This method is promising since biotic elements, such as DNA, viruses, cells 
appear in urine even before people are aware that they might have a trouble and 
accurate detection is important before the condition worsens. Urinalysis using 
dipsticks can be used to acquire preliminary information on the nature of the urine 
sample. However, a more sensitive method is required to confirm the nature of the risk 
posed and to determine the diagnosis. 
The process is based on the use of Capacitance-Voltage measurements to detect the 
presence of blood cells and calculi suspended in urine. Any deviation from the normal 
constituents of urine can be detected because of the changes in the urine electrical 
parameters when exposed to an electric field. This technique can also sense dynamic 
variations in the sample that occur due to the diet and with the increasing lifetime of 
the sample. These dynamic variations can mask the actual values of the electrical 
parameters of the sample. By adding a de-embedding step in the process, this masking 
effect can be removed. Hence, the electrical variations become more appropriate and 
well correlated with the increasing amount of the quantities of the biological entities 
in the sample.  
Electrical charging, capacitance-frequency and capacitance-voltage measurements 
were conducted to extract a set of dielectric constants and other electrical parameters 





different diseases by analyzing the types of exfoliated particles inside the urine is 
promising. This technique can detect cell numbers as low as 100 cells per ml and 
CaOx.H2O at a concentration as low as 10 µg/ml of urine. The comparison of proposed 
method with other available techniques has been depicted in Table 6.1. 
Table 6.1: Comparison of Proposed Method with other available Techniques. 
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Table 6.1: Comparison of Proposed Method with other available Techniques. 
[Contd.] 
This technique can also potentially be used for identifying the type of cells present by 
comparing the capacitance measurements, which could provide a valuable tool for 
discriminating different urine samples of different compositions. Knowing the 
individual electrical response of each cell component can help explain the effect 
observed when these responses are combined. This approach is a highly sensitive, safe, 
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low-cost and reliable method with minimal sample processing. This method can be 
considered a point-of-care test because the results can be instantaneously shared with 
the members of the medical team. 
6.2 Future Scope 
The development of innovative, cheap and rapid electrical detection methods for 
identifying cells and stones in patient samples could potentially provide significant 
public health benefits in terms of early disease detection. Based on these outcomes, 
the proposed method to be an initial point towards creating the foundation for label-
free electrical-based identification and quantification of an unlimited number of nano-
sized particles. 
 
Figure 6.1: Overview of the microfluidic channel-based system. 
The future scope of the study suggests that single entity characterization will be more 
precise towards development of this technique. The composition of biotic materials 
and suspensions on a unit level will help in better understanding of biochemical and 
physiological states. This will help in the exact identification of the type of particles 





which has the potential to provide components identification with higher accuracy. 
Microfluidics can detect individual traits, molecular interactions, and behavior over 
long-time durations, etc. which are the basics of electrical biomarkers, especially in 
proposed methodology of capacitive-voltage detection. 
The basic setup of any microfluidic channel has been depicted in Figure 6.1, which 
incorporates a host where the sample will be loaded. The sample is the urine 
suspension including the possible cells or stones. A pump which is a controlled system 
to regulate the pressure and flow of the sample in microfluidic chamber; a 
microfluidics system with sensing electrodes for analysis of the loaded material where 
the particles are confined. The electrical conditions for investigation can be applied 
with the help of the sensing electrodes. A dedicated embedded system/software for 
microfluidic channel which will provide the measurements and its analysis on 
computer.  
Usually a microcontroller with a closed-loop control algorithm controls the output 
pressure at the requested level. The main part of the system is the electrical analyzer 
which takes sample (for instance, urine) with a regulated flow for its detailed research. 
This analyzer will examine the components (such as, WBCs. RBCs, salts) of the 
sample trapped within the sensing electrodes and provides the results, such as 
capacitance-voltage measurements, etc., when subjected to certain regulated 
conditions. With the slow motion of the flow inside and the size of the channel makes 
it easy to trap individual cells/molecules and explore it. The various pros of using 
microfluidics are to decrease in the sample volume and reagents; pressure, flow, 
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ELECTRON MICROSCOPY METHODS 


































Resolution -0.5–5 nm depth, 
-1–20 nm (lateral) 
-0.1 nm (lateral) 
Problems -SEM requires conductive 
samples 
-needs high vacuum 
- wet materials and 
biological samples 
-Thickness bound is 200 nm 
-time consuming 
-small field of view 
-electron beam can damage 
biological portions 
-for atomic-scale resolution 
ultrahigh vacuum is required 





Table A.3: Comparison of Basic Nanometrology Techniques, Scanning Probe 
Microscopy Methods [137] 
SCANNING PROBE MICROSCOPY METHODS 
Methods Scanning Tunneling 
Microscopy (STM) 
Atomic Force Microscopy (AFM) or  

























-elasticity of the surface 
-magnetic characteristics of the 
surface 
-specific molecular interactions 
Resolution -0.5–5 nm depth 
-2–10 nm (lateral) 
-0.5–5 nm depth 
-0.2–10.0 nm (lateral) 
Problems - conductive samples 
- noise reduction required 
- small scan image size 
- scanning speed is restricted 
- slow rate of scanning leads to 
thermal drift 
- images affected by hysteresis 







Table A.4: Comparison of Basic Nanometrology Techniques, Optical Methods [137] 
OPTIC METHODS 
Methods Dynamic Light Scattering And  




-Colloidal suspensions   
-polymer solutions/melts  
-gels/ liquid crystals  
-amino acids and proteins 







-particle diffusion rate 
- radius  




Resolution 0.5 nm – micrometer range  
Problems -Average particle size, error when 
larger atoms or impurity elements are 
present in a sample 
-In the nanoparticle sample, the analysis 
is biased toward highly refractile 
particles 
-Error due to scattering via 
solid particles in 
heterogeneous samples  






































-Quantitative and qualitative 
elemental composition in 
external layers 
-identification of chemical 
state of the sample elements  
-binding energy and density 
of states 
Resolution - -0.5–10 nm depth 
-0.005–50 µm lateral 
resolution 
Problems Broad peaks from small crystals, 
making it problematic to verify the 
crystalline orientation. 
-Errors in the chemical 
analysis for heterogeneous 
exteriors 
-Degradation during study  





Table A.6: Comparison of Cancer and Tumor Detection Techniques [263]. 









Mammography 68 75 86 70.2 
MRI 94.4 26 73.6 73 
Clinical Checkup 50.4 92.1 94.3 64 
Ultrasound 83.1 34 73.4 68 
Mammogram and Medical 
Checkup 
77.4 72 59 76 
Mammogram and Ultrasound 91 24 71 70 
Mammogram, Medical 
Checkup, and Ultrasound 
93 23 71 70 
Mammogram, Clinical 
Checkup, and MRI 
99.5 7.0 70 70.4 
